The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 57; no. 1; pp. e1 - e45
Main Authors Gordon, Caroline, Amissah-Arthur, Maame-Boatemaa, Gayed, Mary, Brown, Sue, Bruce, Ian N., D'Cruz, David, Empson, Benjamin, Griffiths, Bridget, Jayne, David, Khamashta, Munther, Lightstone, Liz, Norton, Peter, Norton, Yvonne, Schreiber, Karen, Isenberg, David
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2018
Oxford Publishing Limited (England)
Subjects
Adult
Disease Management
Female
Humans
Immunosuppressive agents
Lupus
Lupus Erythematosus, Systemic - diagnosis
Lupus Erythematosus, Systemic - therapy
Male
Medical diagnosis
Middle Aged
Rheumatology - standards
Symptom Assessment - standards
Systemic lupus erythematosus
United Kingdom
assessment
treatment
biologics
management
immunosuppressants
non-biologics
diagnosis
monitoring
lupus
efficacy
Online AccessGet full text

Cover

Author Bruce, Ian N.
Norton, Yvonne
Jayne, David
Amissah-Arthur, Maame-Boatemaa
Gayed, Mary
Khamashta, Munther
D'Cruz, David
Norton, Peter
Brown, Sue
Gordon, Caroline
Schreiber, Karen
Empson, Benjamin
Griffiths, Bridget
Lightstone, Liz
Isenberg, David
Author_xml – sequence: 1
  givenname: Caroline
  surname: Gordon
  fullname: Gordon, Caroline
  email: p.c.gordon@bham.ac.uk
  organization: Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham
– sequence: 2
  givenname: Maame-Boatemaa
  surname: Amissah-Arthur
  fullname: Amissah-Arthur, Maame-Boatemaa
  organization: Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham
– sequence: 3
  givenname: Mary
  surname: Gayed
  fullname: Gayed, Mary
  organization: Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham
– sequence: 4
  givenname: Sue
  surname: Brown
  fullname: Brown, Sue
  organization: Royal National Hospital for Rheumatic Diseases, Bath
– sequence: 5
  givenname: Ian N.
  surname: Bruce
  fullname: Bruce, Ian N.
  organization: Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre
– sequence: 6
  givenname: David
  surname: D'Cruz
  fullname: D'Cruz, David
  organization: Louise Coote Lupus Unit, Guy's Hospital, London
– sequence: 7
  givenname: Benjamin
  surname: Empson
  fullname: Empson, Benjamin
  organization: Laurie Pike Health Centre, Modality Partnership, Birmingham
– sequence: 8
  givenname: Bridget
  surname: Griffiths
  fullname: Griffiths, Bridget
  organization: Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne
– sequence: 9
  givenname: David
  surname: Jayne
  fullname: Jayne, David
  organization: Department of Medicine, University of Cambridge
– sequence: 10
  givenname: Munther
  surname: Khamashta
  fullname: Khamashta, Munther
  organization: Lupus Research Unit, The Rayne Institute, St Thomas' Hospital
– sequence: 11
  givenname: Liz
  surname: Lightstone
  fullname: Lightstone, Liz
  organization: Section of Renal Medicine and Vascular Inflammation, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, London
– sequence: 12
  givenname: Peter
  surname: Norton
  fullname: Norton, Peter
  organization: LUPUS UK, Romford, Essex and
– sequence: 13
  givenname: Yvonne
  surname: Norton
  fullname: Norton, Yvonne
  organization: LUPUS UK, Romford, Essex and
– sequence: 14
  givenname: Karen
  surname: Schreiber
  fullname: Schreiber, Karen
  organization: Division of Women's Health, King's College London
– sequence: 15
  givenname: David
  surname: Isenberg
  fullname: Isenberg, David
  organization: Centre for Rheumatology, University College London, London, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29029350$$D View this record in MEDLINE/PubMed
BookMark eNqNkVtLHDEYhoMo6m77Cwol0Jve7JrDTCa5bKXWwoLg4XrIZL7Zjc4k2xzA-ffOdlXEm3qVhDzP-4W8M3TovAOEvlCypETxs7CBPOjke78ezx7gkUlxgE5pIdiCcM4OX_esOEGzGO8JISXl8hidMEWY4iU5RQ-3G8A_g002bvCNNxbSiDsf8PWbdLzOtoXeOvh3lSZl0E6vYQCXsO9wHGOCwRrc522OGMI4MTs7TifrsG5zn-IndNTpPsLn53WO7i5-3Z5fLlZXv_-c_1gtTCF5WkDLKklVKxvaFIQbQXTVyYYLKFslheoMMYJSpgxlgkolqkZVLS2MAtIpQfkcfd_nboP_myGmerDRQN9rBz7HmqqSFrQqpJrQb-_Qe5-Dm15XM05EWUjJd4Ffn6ncDNDW22AHHcb65RsngO8BE3yMAbpXhJJ6V1b9tqx6X9ZkqXeWsUkn610K2vb_cZd71-fth4Y9ATfushI
CitedBy_id crossref_primary_10_1007_s40272_021_00457_z
crossref_primary_10_1016_j_actatropica_2022_106508
crossref_primary_10_3390_jcm9092709
crossref_primary_10_3390_biom13010171
crossref_primary_10_1016_j_gofs_2020_09_008
crossref_primary_10_1016_j_biopha_2024_117138
crossref_primary_10_1016_j_jep_2021_114815
crossref_primary_10_1080_1744666X_2023_2294938
crossref_primary_10_1016_j_medcli_2023_03_015
crossref_primary_10_1016_j_semarthrit_2023_152346
crossref_primary_10_1007_s11481_023_10075_w
crossref_primary_10_1093_rap_rkab061
crossref_primary_10_1016_j_gpb_2022_08_002
crossref_primary_10_1016_j_autrev_2019_102359
crossref_primary_10_1016_j_intimp_2019_03_010
crossref_primary_10_1136_annrheumdis_2018_214530
crossref_primary_10_53841_bpscpf_2018_1_310_34
crossref_primary_10_1080_14740338_2021_1973428
crossref_primary_10_1080_14397595_2020_1812201
crossref_primary_10_1002_prp2_1255
crossref_primary_10_1371_journal_pone_0270569
crossref_primary_10_1016_j_clinbiochem_2023_110706
crossref_primary_10_3389_fimmu_2022_1074044
crossref_primary_10_1080_1744666X_2018_1529566
crossref_primary_10_1093_rheumatology_keaa403
crossref_primary_10_1136_lupus_2022_000746
crossref_primary_10_7326_M21_2078
crossref_primary_10_1016_j_anai_2024_12_003
crossref_primary_10_1097_RHU_0000000000001727
crossref_primary_10_1016_j_biopha_2024_116261
crossref_primary_10_1177_1759720X211073001
crossref_primary_10_3390_diagnostics14030279
crossref_primary_10_1080_14397595_2018_1494239
crossref_primary_10_1007_s00393_020_00767_6
crossref_primary_10_1016_j_curtheres_2024_100738
crossref_primary_10_3904_kjm_2020_95_3_162
crossref_primary_10_3389_fphar_2021_759095
crossref_primary_10_1016_j_jaut_2022_102798
crossref_primary_10_1177_09612033211022816
crossref_primary_10_1155_2018_2385386
crossref_primary_10_1093_rheumatology_keaa759
crossref_primary_10_1142_S2661341721300056
crossref_primary_10_1093_rheumatology_keae672
crossref_primary_10_1093_mr_roac007
crossref_primary_10_36485_1561_6274_2024_28_4_9_21
crossref_primary_10_1007_s00393_021_00981_w
crossref_primary_10_1093_rap_rkab071
crossref_primary_10_1136_rmdopen_2018_000793
crossref_primary_10_1186_s41927_019_0082_7
crossref_primary_10_1007_s11655_021_3497_0
crossref_primary_10_1016_j_medcle_2023_03_033
crossref_primary_10_1007_s00129_023_05069_x
crossref_primary_10_2478_rir_2020_0009
crossref_primary_10_1007_s11560_022_00588_5
crossref_primary_10_1136_bmjopen_2024_086055
crossref_primary_10_30841_2307_5112_5_6_2020_224822
crossref_primary_10_1007_s10238_019_00600_8
crossref_primary_10_1016_j_clinpr_2020_100062
crossref_primary_10_1038_s41581_024_00901_6
crossref_primary_10_4103_injr_injr_97_22
crossref_primary_10_1007_s10067_018_4286_9
crossref_primary_10_1155_2021_4302515
crossref_primary_10_1177_09612033241308109
crossref_primary_10_1002_acr_25143
crossref_primary_10_1093_rheumatology_key170
crossref_primary_10_1177_0961203318801697
crossref_primary_10_1084_jem_20230559
crossref_primary_10_1053_j_gastro_2022_12_019
crossref_primary_10_1186_s13023_021_01925_y
crossref_primary_10_3389_fmed_2021_651249
crossref_primary_10_1093_rap_rkae017
crossref_primary_10_1007_s00296_024_05593_6
crossref_primary_10_3389_fphar_2022_894550
crossref_primary_10_47360_1995_4484_2021_384_393
crossref_primary_10_1016_j_bcp_2019_04_009
crossref_primary_10_1002_art_42645
crossref_primary_10_1016_j_semarthrit_2020_01_014
crossref_primary_10_1038_s41584_018_0133_2
crossref_primary_10_1177_0961203319842641
crossref_primary_10_2174_1573398X16999201202121247
crossref_primary_10_1038_s41584_020_0372_x
crossref_primary_10_1136_annrheumdis_2019_215794
crossref_primary_10_1186_s43166_023_00187_9
crossref_primary_10_2217_pgs_2022_0063
crossref_primary_10_3390_medicina60071171
crossref_primary_10_1093_rheumatology_keab373
crossref_primary_10_3389_fimmu_2024_1454747
crossref_primary_10_3389_fmed_2018_00161
crossref_primary_10_1080_1744666X_2022_2040988
crossref_primary_10_1134_S207908642102002X
crossref_primary_10_1177_0961203318801670
crossref_primary_10_1007_s00296_018_4059_4
crossref_primary_10_1002_jca_22043
crossref_primary_10_1016_j_ijantimicag_2020_106214
crossref_primary_10_7475_kjan_2022_34_3_324
crossref_primary_10_1007_s00393_019_0633_8
crossref_primary_10_1007_s00467_024_06405_6
crossref_primary_10_1186_s12948_018_0089_4
crossref_primary_10_1080_14712598_2021_1841164
crossref_primary_10_1093_rheumatology_keaa142
crossref_primary_10_1016_j_clim_2019_108274
crossref_primary_10_1016_j_intimp_2023_111269
crossref_primary_10_1093_rheumatology_keac685
crossref_primary_10_3390_ijms22147619
crossref_primary_10_7759_cureus_70090
crossref_primary_10_1111_bjh_19635
crossref_primary_10_1097_HJH_0000000000002405
crossref_primary_10_12968_pnur_2022_33_9_372
crossref_primary_10_1080_13696998_2020_1740236
crossref_primary_10_1016_j_ijantimicag_2020_106101
crossref_primary_10_1080_14740338_2023_2203482
crossref_primary_10_1002_msc_1712
crossref_primary_10_1093_rheumatology_kex291
crossref_primary_10_3390_jcm12093198
crossref_primary_10_1007_s10067_023_06523_w
crossref_primary_10_1016_j_thromres_2020_10_005
crossref_primary_10_1007_s00393_018_0532_4
crossref_primary_10_3899_jrheum_180310
crossref_primary_10_31744_einstein_journal_2020AO5322
crossref_primary_10_1016_j_autrev_2020_102668
crossref_primary_10_1093_rheumatology_keac552
crossref_primary_10_1177_09612033241301515
crossref_primary_10_1016_j_microc_2021_106677
crossref_primary_10_20517_2574_1209_2023_142
crossref_primary_10_1093_rheumatology_keac558
crossref_primary_10_1093_rheumatology_keac559
crossref_primary_10_1177_09612033251325687
crossref_primary_10_1007_s10067_020_05230_0
crossref_primary_10_1177_09612033241242692
crossref_primary_10_1002_art_40932
crossref_primary_10_1080_1744666X_2018_1450141
crossref_primary_10_1177_09612033221132484
crossref_primary_10_3389_fmicb_2024_1319654
crossref_primary_10_2147_POR_S442959
crossref_primary_10_1016_j_rdc_2022_05_001
crossref_primary_10_1136_practneurol_2022_003424
crossref_primary_10_1177_09612033211066481
crossref_primary_10_1136_lupus_2019_000337
crossref_primary_10_1093_rap_rkaa016
crossref_primary_10_1186_s12882_019_1560_2
crossref_primary_10_47102_annals_acadmedsg_2023262
crossref_primary_10_1093_rheumatology_keac551
crossref_primary_10_1136_lupus_2019_000350
crossref_primary_10_1093_rap_rkaa006
crossref_primary_10_1093_rheumatology_keab334
crossref_primary_10_1080_25785826_2024_2447629
crossref_primary_10_1007_s40746_023_00284_z
crossref_primary_10_1136_bmjopen_2019_032569
crossref_primary_10_1021_acsomega_3c06293
crossref_primary_10_1093_stcltm_szae044
crossref_primary_10_1177_0961203320930099
crossref_primary_10_3390_jcm7120477
crossref_primary_10_1136_rmdopen_2024_005118
crossref_primary_10_1136_lupus_2024_001317
crossref_primary_10_3389_fnut_2024_1208074
crossref_primary_10_1002_ccr3_2550
crossref_primary_10_1007_s00296_018_4111_4
crossref_primary_10_1016_j_artmed_2024_103042
crossref_primary_10_1016_j_semarthrit_2024_152472
crossref_primary_10_1136_lupus_2024_001434
crossref_primary_10_1177_0961203319896626
crossref_primary_10_1016_j_jaci_2022_01_025
crossref_primary_10_1136_lupus_2017_000240
crossref_primary_10_1016_j_joim_2020_08_007
crossref_primary_10_1136_annrheumdis_2021_220363
crossref_primary_10_33393_grhta_2022_2470
crossref_primary_10_1080_13543784_2019_1599859
crossref_primary_10_1177_09612033211014267
crossref_primary_10_1016_j_ejim_2024_08_008
crossref_primary_10_3892_etm_2023_12067
crossref_primary_10_1080_08820139_2025_2475816
crossref_primary_10_1080_09638288_2024_2353855
crossref_primary_10_1177_02692155221111927
crossref_primary_10_1016_j_cnur_2018_04_002
crossref_primary_10_1097_MD_0000000000032520
crossref_primary_10_1136_lupus_2017_000253
crossref_primary_10_30841_2307_5112_2_2019_174634
crossref_primary_10_1136_bcr_2021_248476
crossref_primary_10_14412_1995_4484_2019_3_40
crossref_primary_10_1016_j_rdc_2021_04_009
crossref_primary_10_1097_MOP_0000000000001396
crossref_primary_10_1093_rap_rkad093
crossref_primary_10_4236_ojim_2020_102012
crossref_primary_10_1093_rheumatology_keaa468
crossref_primary_10_1016_j_xcrm_2022_100894
crossref_primary_10_2174_1381612826666200707132920
crossref_primary_10_1007_s12325_022_02160_y
crossref_primary_10_1007_s00296_020_04726_x
crossref_primary_10_1016_S2665_9913_23_00091_7
crossref_primary_10_1186_s12882_020_01915_5
crossref_primary_10_1024_1661_8157_a003443
crossref_primary_10_1093_rheumatology_kez422
crossref_primary_10_1016_j_clinthera_2023_04_013
crossref_primary_10_1093_rheumatology_keab306
crossref_primary_10_1177_0961203319861687
crossref_primary_10_3899_jrheum_191187
crossref_primary_10_1007_s40257_023_00774_8
crossref_primary_10_1038_s41419_023_05680_9
crossref_primary_10_1177_0961203320919499
crossref_primary_10_1002_tre_732
crossref_primary_10_3346_jkms_2019_34_e185
crossref_primary_10_1097_BOR_0000000000000527
crossref_primary_10_1007_s10067_022_06494_4
crossref_primary_10_1177_0961203320910797
crossref_primary_10_3899_jrheum_171459
crossref_primary_10_1016_S2665_9913_24_00338_2
crossref_primary_10_17925_RMD_2023_2_2_1
crossref_primary_10_1093_rheumatology_keab534
crossref_primary_10_3390_jcm11226632
crossref_primary_10_1002_jca_21705
crossref_primary_10_1038_nrneph_2017_188
crossref_primary_10_1016_j_berh_2023_101873
crossref_primary_10_1097_01_NPR_0000000000000071
crossref_primary_10_1177_1759720X19874309
crossref_primary_10_3389_fimmu_2023_1157196
crossref_primary_10_1186_s13075_022_02799_6
crossref_primary_10_1007_s40744_023_00595_5
crossref_primary_10_1093_mr_roae058
crossref_primary_10_1136_bmjophth_2024_001898
crossref_primary_10_1097_MD_0000000000015030
crossref_primary_10_1097_RHU_0000000000001803
crossref_primary_10_3390_pharmaceutics14040877
crossref_primary_10_1111_ced_14648
crossref_primary_10_1016_j_autrev_2023_103479
crossref_primary_10_1093_rap_rkad109
crossref_primary_10_4103_ejh_ejh_61_22
crossref_primary_10_1186_s42358_021_00202_7
crossref_primary_10_1080_1744666X_2024_2324005
crossref_primary_10_1136_annrheumdis_2019_215716
crossref_primary_10_4103_jesnt_jesnt_13_21
crossref_primary_10_1093_mr_roae072
crossref_primary_10_1177_09612033211024355
crossref_primary_10_47360_1995_4484_2022_397_412
crossref_primary_10_1136_ard_2022_223328
crossref_primary_10_3390_healthcare12161603
crossref_primary_10_3390_jcm13082211
crossref_primary_10_1371_journal_pone_0285889
crossref_primary_10_1093_rap_rkaa072
crossref_primary_10_1136_lupus_2021_000617
crossref_primary_10_1093_femspd_ftaa046
crossref_primary_10_1002_bcp_70047
crossref_primary_10_1093_rheumatology_keae592
crossref_primary_10_1007_s40273_022_01166_2
crossref_primary_10_1097_RHU_0000000000001265
crossref_primary_10_1093_jalm_jfab104
crossref_primary_10_1177_0961203319829826
crossref_primary_10_1177_09612033221138360
crossref_primary_10_3389_fmed_2025_1429337
crossref_primary_10_1016_S0140_6736_19_30546_X
crossref_primary_10_1136_lupus_2021_000504
crossref_primary_10_1177_09612033231187229
crossref_primary_10_1177_09612033221129774
Cites_doi 10.1093/rheumatology/kep064
10.1191/096120300678828794
10.3899/jrheum.121368
10.1093/rheumatology/kep396
10.1191/096120300678828082
10.1097/RHU.0b013e31819d8489
10.1097/01.md.0000104742.42401.e2
10.1016/j.rdc.2014.04.005
10.1097/MD.0000000000000086
10.1002/acr.21664
10.1093/ckj/sfu096
10.1191/096120399678841007
10.1136/lupus-2014-000031
10.1136/annrheumdis-2012-202844
10.1002/art.21358
10.1016/j.autrev.2010.08.016
10.1002/acr.20097
10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8
10.1191/096120300676096627
10.1002/art.24068
10.1002/art.1780210107
10.3899/jrheum.090306
10.1016/j.semarthrit.2014.04.002
10.1016/S0140-6736(95)90114-0
10.1002/acr.22173
10.3899/jrheum.081194
10.1002/art.30613
10.1177/0961203313512883
10.1093/rheumatology/ker101
10.1016/j.trsl.2010.07.009
10.1093/rheumatology/ket355
10.1196/annals.1351.048
10.1136/ard.2006.068676
10.1177/0961203308100481
10.1016/j.reprotox.2013.04.005
10.1136/annrheumdis-2013-205139
10.3109/s10165-007-0565-z
10.3109/09537101003735564
10.1177/0961203312447868
10.1191/0961203306lu2250rr
10.1136/annrheumdis-2013-204838
10.1191/0961203306lu2299oa
10.1007/s005990070017
10.1002/art.25052
10.1111/j.1600-0897.1992.tb00789.x
10.1136/ard.62.6.534
10.1002/art.38238
10.1002/art.24741
10.1007/s11926-015-0539-7
10.1016/j.jaut.2012.12.009
10.1001/archderm.1991.04510010083008
10.1136/lupus-2014-000066
10.1016/j.berh.2005.04.002
10.1002/art.1780240503
10.1056/NEJM197301182880303
10.1053/sarh.2002.50003
10.1002/art.22881
10.1093/rheumatology/kem173
10.1161/CIRCULATIONAHA.111.089268
10.1136/ard.2008.093013
10.1182/blood-2011-03-340232
10.1016/j.jaut.2014.01.004
10.1136/ard.2006.069039
10.1002/art.21955
10.1002/art.27289
10.1002/art.1780400106
10.1002/art.34359
10.1016/S0140-6736(13)60889-2
10.1002/art.22198
10.1002/art.20430
10.1136/annrheumdis-2013-205171
10.1056/NEJM196805022781818
10.3899/jrheum.070968
10.1191/0961203303lu251oa
10.1002/art.1780400928
10.1111/bjh.13568
10.1093/rheumatology/35.7.669
10.1016/j.semarthrit.2013.05.003
10.1093/rheumatology/39.11.1301
10.1007/s12016-009-8190-6
10.1002/art.21263
10.1177/0961203313509295
10.1034/j.1600-0781.2000.160604.x
10.1136/annrheumdis-2011-200831
10.1016/j.autrev.2015.08.010
10.1111/j.1756-185X.2011.01665.x
10.1136/annrheumdis-2011-200937
10.1136/annrheumdis-2014-206334
10.1093/rheumatology/kem153
10.1111/exd.12428
10.3109/14397595.2015.1060665
10.1136/ard.2009.117200
10.1056/NEJMoa1014460
10.1191/0961203303lu337oa
10.1177/096120339700600407
10.1191/0961203304lu1099oa
10.1093/rheumatology/keu406
10.1093/rheumatology/ker368
10.1007/s10067-014-2839-0
10.1177/0961203308101714
10.1517/14740338.2011.566555
10.1093/rheumatology/ker337
10.1177/0961203311409273
10.1093/rheumatology/kev405
10.1136/ard.39.4.377
10.1002/art.27371
10.1093/rheumatology/41.6.643
10.1093/rheumatology/ken046
10.1016/j.semarthrit.2004.07.002
10.1002/art.27541
10.1002/art.10461
10.1111/j.1744-9987.1997.tb00057.x
10.1002/art.20426
10.1016/j.jaad.2010.06.017
10.1002/art.24699
10.1016/j.autrev.2010.12.008
10.1016/j.jaad.2010.06.018
10.1093/rheumatology/ket160
10.1136/bmj.1.5801.645
10.1093/rheumatology/kev311
10.1002/art.24966
10.1191/096120301678416033
10.1136/ard.2010.131995
10.1136/ard.2004.033100
10.1016/S0002-9343(03)00135-9
10.1056/NEJMra071297
10.1517/14740338.3.4.273
10.1016/j.jaad.2014.12.025
10.1136/ard.2006.067108
10.1136/ard.2007.076059
10.3109/s10165-009-0220-y
10.1002/art.10752
10.1080/08916930400022616
10.1136/annrheumdis-2012-202106
10.1016/j.transci.2014.08.001
10.1191/096120301676669495
10.1016/j.autrev.2011.10.009
10.1093/rheumatology/ker176
10.1177/0961203308094653
10.1191/0961203306lu2345oa
10.1056/NEJMoa031855
10.1002/acr.20648
10.1177/0961203309351541
10.1177/0961203306072426
10.1002/art.27308
10.1046/j.1365-2133.2003.05379.x
10.1111/1756-185X.12337
10.1136/ard.61.1.70
10.1093/rheumatology/ket488
10.1136/ard.47.6.496
10.1191/096120301678646137
10.1016/j.survophthal.2015.06.003
10.1093/rheumatology/38.10.917
10.1177/0961203308099242
10.1136/ard.2006.062984
10.1177/0961203310366572
10.1016/j.berh.2009.04.005
10.1177/096120339600500313
10.1191/0961203302lu204oa
10.1177/0961203315593164
10.1385/CRIAI:29:3:219
10.1177/0961203310395055
10.1136/ard.2006.057885
10.1177/0961203313503912
10.1002/art.22046
10.1136/ard.41.4.347
10.1002/art.34473
10.3899/jrheum.100007
10.3899/jrheum.100575
10.1136/ard.2008.101766
10.1191/0961203306lu2266oa
10.1177/0961203310395803
10.1007/s00198-012-2157-9
10.1016/0091-6749(73)90062-6
10.1093/ndt/gfq256
10.1093/rheumatology/keu343
10.1002/art.1780160204
10.1136/ard.2004.029694
10.1136/ard.2010.132068
10.1002/art.22079
10.1053/S0049-0172(03)00133-1
10.1191/0961203306lu2271oa
10.1002/art.21053
10.1016/j.semarthrit.2008.10.007
10.1177/0961203307079502
10.1016/S0140-6736(10)61354-2
10.1177/0961203309350320
10.1136/ard.2004.025528
10.3899/jrheum.140577
10.1177/0961203313493032
10.1002/pds.3437
10.7326/0003-4819-142-12_Part_1-200506210-00004
10.1002/art.30466
10.1002/art.1780371212
10.1177/0961203314524292
10.1002/art.22156
10.1177/0961203313519158
10.1191/0961203305lu2228oa
10.7326/0003-4819-119-5-199309010-00003
10.1177/0961203396005001051
10.1111/j.1365-2133.1992.tb14851.x
10.1093/ndt/gfn360
10.1093/rheumatology/kev036
10.1002/art.1780390303
10.1191/096120301666080831
10.1191/0961203306lu2308oa
10.1177/0961203309106831
10.1093/rheumatology/kew479
10.1177/0961203309358600
10.1159/000189327
10.1007/BF01419725
10.1002/art.22224
10.1002/acr.22422
10.1177/0961203309104392
10.1016/j.rdc.2005.01.009
10.1002/acr.20133
10.3109/s10165-012-0707-9
10.1016/j.berh.2005.03.010
10.1007/s10067-013-2312-5
10.1136/bmjopen-2013-002852
10.1093/rheumatology/kes158
10.1007/BF02032333
10.1093/rheumatology/keu412
10.1093/rheumatology/39.12.1316
10.1080/03009740701607042
10.1177/0961203312446627
10.3109/s10165-012-0656-3
10.1097/01.md.0000091181.93122.55
10.1002/art.22159
10.1136/annrheumdis-2012-202322
10.1007/s12016-011-8278-7
10.1016/j.berh.2013.10.003
10.1136/ard.2007.070367
10.1007/s12026-014-8609-x
10.1177/0961203310393378
10.1002/art.1780390304
10.1097/00005792-199711000-00006
10.1093/rheumatology/ken510
10.1177/0961203310385738
10.1002/art.39085
10.1191/0961203305lu2157oa
10.1111/1756-185X.12179
10.1093/rheumatology/41.8.876
10.1186/ar3402
10.3899/jrheum.130704
10.1097/00124743-199908000-00010
10.1002/art.27286
10.1177/0961203309106174
10.1080/09546630310018789
10.1002/art.38239
10.1191/0961203305lu2043rr
10.1016/S0140-6736(13)61499-3
10.1111/1756-185X.12551
10.1016/j.autrev.2013.04.006
10.1016/j.jaut.2014.11.004
10.1191/0961203306lu2313oa
10.1002/art.1780240901
10.1002/art.24679
10.1002/art.21039
10.1002/art.27233
10.1191/096120301675962535
10.1002/art.34400
10.1038/jid.2011.167
10.1016/j.ophtha.2010.11.017
10.1136/ard.56.6.382
10.1136/ard.59.6.487
10.1001/archdermatol.2011.191
10.7326/0003-4819-125-7-199610010-00003
10.1002/art.1780330505
10.1056/NEJM199101173240303
10.1007/s12016-015-8469-8
10.1136/ard.46.10.773
10.1111/j.1774-9987.2005.00221.x
10.1191/096120398678919778
10.1136/annrheumdis-2012-201940
10.1002/acr.22035
10.1177/0961203310395802
10.1016/S0140-6736(14)60128-8
10.1093/rheumatology/kei080
10.1067/mpd.2003.233
10.1177/0961203309351033
10.1016/S0002-9343(99)80078-3
10.1093/rheumatology/keu429
10.1136/ard.2007.077594
10.1002/art.34564
10.1097/00002281-199405000-00011
10.1191/0961203304lu509oa
10.1002/art.10142
10.1177/0961203313519159
10.1177/0961203308099471
10.1093/rheumatology/keh238
10.1002/art.1780140511
10.1177/0961203311418706
10.1093/rheumatology/kev357
10.7326/0003-4819-83-5-597
10.1191/0961203306lu2292oa
10.1007/s10067-015-2941-y
10.1016/S0889-857X(21)00234-9
10.1111/exd.12035
10.1001/archdermatol.2011.2558
10.1002/art.1780380415
10.1093/rheumatology/kev404
10.1007/s10067-015-2987-x
10.1016/j.semarthrit.2004.06.003
10.1002/art.24538
10.1093/rheumatology/kep062
10.1002/art.11304
10.1093/rheumatology/kep346
10.1136/jcp.35.10.1118
10.1681/ASN.2008101028
10.1056/NEJM199205213262101
10.1002/art.1780400506
10.1007/s12016-007-8028-z
10.1002/art.24937
10.1111/bjd.12378
10.1111/j.1600-0781.2008.00373.x
10.1093/rheumatology/kel216a
10.1002/art.1780370416
10.1136/ard.2009.119263
10.1191/0961203302lu203ra
10.3899/jrheum.090019
10.1038/nrrheum.2010.62
10.1136/ard.2010.130476
10.1191/0961203305lu2174rr
10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A
10.1002/art.27350
10.1016/j.jaad.2009.12.053
10.1186/s13075-015-0521-9
10.1177/0961203307081840
10.1097/BOR.0000000000000085
10.1111/j.1399-0012.2010.01255.x
10.1002/art.22683
10.1191/0961203304lu1067sr
10.1093/rheumatology/keq026
10.1136/ard.51.12.1318
10.1136/ard.2006.067835
10.1016/0272-6386(95)90488-3
10.1111/j.1445-5994.1974.tb03165.x
10.1136/ard.45.5.359
10.1016/S0140-6736(13)60954-X
10.1136/ard.2008.102533
10.1002/acr.22539
10.1136/ard.2008.094508
10.1007/s00296-010-1366-9
10.1002/art.1780251101
10.1191/0961203302lu243oa
10.1177/0961203310388445
10.1186/ar3919
ContentType Journal Article
Copyright The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2017
The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com
Copyright_xml – notice: The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2017
– notice: The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com
CorporateAuthor for the British Society for Rheumatology Standards, Audit and Guidelines Working Group
British Society for Rheumatology Standards, Audit and Guidelines Working Group
CorporateAuthor_xml – name: for the British Society for Rheumatology Standards, Audit and Guidelines Working Group
– name: British Society for Rheumatology Standards, Audit and Guidelines Working Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
NAPCQ
7X8
DOI 10.1093/rheumatology/kex286
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1462-0332
EndPage e45
ExternalDocumentID 29029350
10_1093_rheumatology_kex286
10.1093/rheumatology/kex286
Genre Journal Article
Practice Guideline
GrantInformation_xml – fundername: Medical Research Council
  grantid: MR/M01665X/1
– fundername: Arthritis Research UK
  grantid: 20108
– fundername: Medical Research Council
  grantid: MR/M026345/1
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
29P
2WC
354
4.4
48X
53G
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABEJV
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MHKGH
N9A
NGC
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OBH
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RHF
ROL
ROX
RUSNO
RW1
RXO
SV3
TCURE
TEORI
TJX
TR2
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
ZY1
~91
AAYXX
ABDFA
ABGNP
ABVGC
ADNBA
AEMQT
AGORE
AJBYB
AJNCP
ALXQX
CITATION
JXSIZ
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c483t-ed27819d8b1b403c60a7f8b36e5d9869fc0c61129c12618967b97d14c9e0f9613
ISSN 1462-0324
1462-0332
IngestDate Thu Jul 10 22:14:49 EDT 2025
Mon Jun 30 16:56:19 EDT 2025
Mon Jul 21 06:04:05 EDT 2025
Tue Jul 01 04:03:50 EDT 2025
Thu Apr 24 23:01:10 EDT 2025
Fri Dec 06 10:16:14 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords assessment
treatment
biologics
management
immunosuppressants
non-biologics
diagnosis
monitoring
lupus
efficacy
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c483t-ed27819d8b1b403c60a7f8b36e5d9869fc0c61129c12618967b97d14c9e0f9613
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Instructional Material/Guideline-3
content type line 23
OpenAccessLink https://academic.oup.com/rheumatology/article-pdf/57/1/e1/22779088/kex286.pdf
PMID 29029350
PQID 2306548831
PQPubID 41027
ParticipantIDs proquest_miscellaneous_1951417489
proquest_journals_2306548831
pubmed_primary_29029350
crossref_primary_10_1093_rheumatology_kex286
crossref_citationtrail_10_1093_rheumatology_kex286
oup_primary_10_1093_rheumatology_kex286
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Rheumatology (Oxford, England)
PublicationTitleAlternate Rheumatology (Oxford)
PublicationYear 2018
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – sequence: 0
  name: Oxford University Press
– name: Oxford Publishing Limited (England)
References Illei ( key 20180328150036_kex286-B45) 2002; 46
Remer ( key 20180328150036_kex286-B185) 2001; 10
Callen ( key 20180328150036_kex286-B158) 1991; 127
Hickman ( key 20180328150036_kex286-B199) 2015; 34
Gansauge ( key 20180328150036_kex286-B127) 1997; 56
Herzinger ( key 20180328150036_kex286-B140) 2004; 50
Clowse ( key 20180328150036_kex286-B90) 2006; 54
Steinberg ( key 20180328150036_kex286-B364) 1973; 52
Askanase ( key 20180328150036_kex286-B156) 2009; 36
Steiman ( key 20180328150036_kex286-B62) 2010; 37
Parker ( key 20180328150036_kex286-B76) 2013; 72
Bijl ( key 20180328150036_kex286-B164) 2003; 62
Bernatsky ( key 20180328150036_kex286-B304) 2006; 33
Zandman-Goddard ( key 20180328150036_kex286-B226) 2005; 29
Johnson ( key 20180328150036_kex286-B5) 1995; 38
Neuwelt ( key 20180328150036_kex286-B371) 1995; 98
Cimaz ( key 20180328150036_kex286-B64) 2003; 142
Bertsias ( key 20180328150036_kex286-B22) 2008; 67
Ines ( key 20180328150036_kex286-B262) 2015; 67
Wong ( key 20180328150036_kex286-B318) 2005; 14
Rovin ( key 20180328150036_kex286-B352) 2012; 64
Pons-Estel ( key 20180328150036_kex286-B27) 2004; 83
Danowski ( key 20180328150036_kex286-B142) 2006; 33
Islam ( key 20180328150036_kex286-B125) 2012; 15
Horizon ( key 20180328150036_kex286-B134); 3
Ho ( key 20180328150036_kex286-B44) 2001; 44
Perricone ( key 20180328150036_kex286-B221) 2008; 47
Toubi ( key 20180328150036_kex286-B307) 2000; 9
Pinto ( key 20180328150036_kex286-B383) 2011; 20
Merrill ( key 20180328150036_kex286-B190) 2010; 62
Stojanovich ( key 20180328150036_kex286-B187) 2003; 12
Wallin ( key 20180328150036_kex286-B344) 2009; 34
Marengo ( key 20180328150036_kex286-B79) 2012; 21
Arnal ( key 20180328150036_kex286-B216) 2002; 29
Ogawa ( key 20180328150036_kex286-B178) 2010; 19
Wallace ( key 20180328150036_kex286-B205) 2009; 61
Tam ( key 20180328150036_kex286-B184) 2004; 13
Hebert ( key 20180328150036_kex286-B289) 1995; 26
Furie ( key 20180328150036_kex286-B204) 2011; 63
Ginzler ( key 20180328150036_kex286-B159) 2010; 62
Ruiz-Irastorza ( key 20180328150036_kex286-B273) 2004; 13
Chambers ( key 20180328150036_kex286-B15) 2009; 48
Gladman ( key 20180328150036_kex286-B275) 1997; 40
Ramos-Casals ( key 20180328150036_kex286-B382) 2010; 28
Caccavo ( key 20180328150036_kex286-B175) 1997; 40
Rahman ( key 20180328150036_kex286-B327) 1997; 76
Armenti ( key 20180328150036_kex286-B339) 2002
Mok ( key 20180328150036_kex286-B42) 2005; 19
Jung ( key 20180328150036_kex286-B102) 2010; 62
Martinelli ( key 20180328150036_kex286-B378) 1996; 74
Birnbaum ( key 20180328150036_kex286-B51) 2009; 60
Ighe ( key 20180328150036_kex286-B261) 2015; 17
Lipnick ( key 20180328150036_kex286-B341) 1985; 12
Edwards ( key 20180328150036_kex286-B143) 1987; 46
Ward ( key 20180328150036_kex286-B282) 2006; 33
Jones ( key 20180328150036_kex286-B230) 1981; 24
Sato ( key 20180328150036_kex286-B317) 2001; 10
Sutton ( key 20180328150036_kex286-B12) 2013; 43
Wang ( key 20180328150036_kex286-B115) 1999; 26
Fox ( key 20180328150036_kex286-B157) 1994; 20
Wilson ( key 20180328150036_kex286-B126) 1994; 21
Leandro ( key 20180328150036_kex286-B394) 2005; 44
Harada ( key 20180328150036_kex286-B399) 1997; 1
Quartuccio ( key 20180328150036_kex286-B179) 2006; 15
Wahie ( key 20180328150036_kex286-B310) 2013; 169
Molloy ( key 20180328150036_kex286-B355) 2009; 60
Ginzler ( key 20180328150036_kex286-B208) 2014; 41
Patsinakidis ( key 20180328150036_kex286-B138) 2012; 21
Somers ( key 20180328150036_kex286-B33) 2014; 66
Friedman ( key 20180328150036_kex286-B211) 2010; 62
Furie ( key 20180328150036_kex286-B360) 2014; 1
Hernandez-Cruz ( key 20180328150036_kex286-B111) 2001; 19
( key 20180328150036_kex286-B245) 1999; 42
Ruperto ( key 20180328150036_kex286-B283) 2011; 20
González ( key 20180328150036_kex286-B107) 2009; 18
Vital ( key 20180328150036_kex286-B353) 2015; 67
The SELENA-SLEDAI index, (Appendix B) ( key 20180328150036_kex286-B272) 2007
Zhang ( key 20180328150036_kex286-B114) 2009; 15
Izmirly ( key 20180328150036_kex286-B312) 2012; 126
Tokuda ( key 20180328150036_kex286-B176) 1994; 37
Kipen ( key 20180328150036_kex286-B128) 1997; 6
Orbach ( key 20180328150036_kex286-B397) 2004; 34
Fernandez-Nebro ( key 20180328150036_kex286-B385) 2012; 21
Bootsma ( key 20180328150036_kex286-B60) 1995; 345
Posalski ( key 20180328150036_kex286-B166) 2009; 18
Cervera ( key 20180328150036_kex286-B253) 2015; 74
Amezcua-Guerra ( key 20180328150036_kex286-B263) 2015; 67
Sultan ( key 20180328150036_kex286-B247) 1999; 38
Lourdudoss ( key 20180328150036_kex286-B168) 2014; 23
Bertsias ( key 20180328150036_kex286-B23) 2010; 69
Galarza ( key 20180328150036_kex286-B393) 2008; 34
Tsakonas ( key 20180328150036_kex286-B95) 1998; 7
Alarcón ( key 20180328150036_kex286-B112) 2007; 66
Sherer ( key 20180328150036_kex286-B215) 2008; 10
Papagiannuli ( key 20180328150036_kex286-B250) 2016; 61
Costedoat-Chalumeau ( key 20180328150036_kex286-B96) 2007; 66
Pengo ( key 20180328150036_kex286-B254) 2011; 118
Ginzler ( key 20180328150036_kex286-B331) 1978; 21
Barber ( key 20180328150036_kex286-B92) 2006; 15
Pons-Estel ( key 20180328150036_kex286-B104) 2009; 61
Yahya ( key 20180328150036_kex286-B172) 2013; 16
Nuttall ( key 20180328150036_kex286-B265) 2013; 27
Diaz-Lagares ( key 20180328150036_kex286-B396) 2012; 11
Wahie ( key 20180328150036_kex286-B94) 2011; 131
Nikpour ( key 20180328150036_kex286-B48) 2009; 61
Chakravarty ( key 20180328150036_kex286-B337) 2008; 47
Ong ( key 20180328150036_kex286-B298) 2016; 25
Sanders ( key 20180328150036_kex286-B323) 2003; 149
Pons-Estel ( key 20180328150036_kex286-B260) 2014; 23
Rao ( key 20180328150036_kex286-B266) 2014; 26
Petri ( key 20180328150036_kex286-B258) 2012; 64
Diav-Citrin ( key 20180328150036_kex286-B100) 2013; 39
Bruce ( key 20180328150036_kex286-B14) 2015; 74
NICE ( key 20180328150036_kex286-B324)
Pyne ( key 20180328150036_kex286-B296) 2002; 61
Pagnoux ( key 20180328150036_kex286-B236) 2005; 14
Merrill ( key 20180328150036_kex286-B207) 2012; 64
Petri ( key 20180328150036_kex286-B188) 2010; 62
Costedoat-Chalumeau ( key 20180328150036_kex286-B97) 2003; 48
Ostensen ( key 20180328150036_kex286-B320) 2000; 9
Nannini ( key 20180328150036_kex286-B165) 2009; 18
Appel ( key 20180328150036_kex286-B349) 2009; 20
Peponis ( key 20180328150036_kex286-B248) 2006; 15
Jun ( key 20180328150036_kex286-B332) 2005; 23
Houssiau ( key 20180328150036_kex286-B369) 2010; 69
Morand ( key 20180328150036_kex286-B116) 1992; 51
Fortin ( key 20180328150036_kex286-B124) 2008; 59
Tsang ( key 20180328150036_kex286-B118) 2014; 32
Suzuki ( key 20180328150036_kex286-B183) 2011; 31
Abarientos ( key 20180328150036_kex286-B99) 2011; 10
Carneiro ( key 20180328150036_kex286-B123) 1999; 26
Meinao ( key 20180328150036_kex286-B83) 1996; 5
Goldblatt ( key 20180328150036_kex286-B41) 2013; 382
Font ( key 20180328150036_kex286-B28) 2004; 33
Izmirly ( key 20180328150036_kex286-B103) 2010; 69
Kuhn ( key 20180328150036_kex286-B288) 2011; 65
Man ( key 20180328150036_kex286-B374) 2014; 17
Iaccarino ( key 20180328150036_kex286-B196) 2015; 33
ter Borg ( key 20180328150036_kex286-B59) 1990; 33
Smith ( key 20180328150036_kex286-B391) 2006; 54
Bernatsky ( key 20180328150036_kex286-B9) 2006; 54
Yee ( key 20180328150036_kex286-B269) 2010; 49
Bertoli ( key 20180328150036_kex286-B54) 2007; 46
Al Sawah ( key 20180328150036_kex286-B306) 2015; 2
Ballou ( key 20180328150036_kex286-B145) 1985; 12
Isenberg ( key 20180328150036_kex286-B350) 2010; 49
Gladman ( key 20180328150036_kex286-B286) 1996; 39
Molad ( key 20180328150036_kex286-B109) 2002; 11
Francioni ( key 20180328150036_kex286-B210) 1994; 12
Ho ( key 20180328150036_kex286-B299) 2001; 44
Hochberg ( key 20180328150036_kex286-B256) 1997; 40
Wilke ( key 20180328150036_kex286-B131) 1991; 9
Firooz ( key 20180328150036_kex286-B69) 2011; 20
Sakthiswary ( key 20180328150036_kex286-B227) 2014; 93
NHS England ( key 20180328150036_kex286-B267)
Nyberg ( key 20180328150036_kex286-B346) 1981; 24
Lateef ( key 20180328150036_kex286-B242) 2012; 14
Amaral ( key 20180328150036_kex286-B30) 2014; 53
Ruiz-Irastorza ( key 20180328150036_kex286-B241) 2011; 20
Varas-Lorenzo ( key 20180328150036_kex286-B322) 2013; 22
Somers ( key 20180328150036_kex286-B6) 2007; 57
van Vollenhoven ( key 20180328150036_kex286-B71) 2014; 73
Vila ( key 20180328150036_kex286-B136) 1999; 18
Murphy ( key 20180328150036_kex286-B31) 2013; 52
Pons-Estel ( key 20180328150036_kex286-B108) 2010; 62
Isenberg ( key 20180328150036_kex286-B284) 2011; 70
Leblanc-Trudeau ( key 20180328150036_kex286-B358) 2015; 42
Chasset ( key 20180328150036_kex286-B122) 2015; 72
Kuhn ( key 20180328150036_kex286-B287) 2011; 65
Houssiau ( key 20180328150036_kex286-B368) 2002; 46
Stoll ( key 20180328150036_kex286-B73) 2004; 43
Moroni ( key 20180328150036_kex286-B285) 2009; 68
Gordon ( key 20180328150036_kex286-B290) 2009; 18
Williams ( key 20180328150036_kex286-B82) 1994; 21
Morton ( key 20180328150036_kex286-B177) 2000; 59
McHardy ( key 20180328150036_kex286-B38) 1982; 35
Pisoni ( key 20180328150036_kex286-B212) 2010; 62
Somers ( key 20180328150036_kex286-B376) 2005; 52
Urowitz ( key 20180328150036_kex286-B34) 2012; 64
Ishizaki ( key 20180328150036_kex286-B300) 2015; 54
Petri ( key 20180328150036_kex286-B58) 2009; 36
McElhone ( key 20180328150036_kex286-B277) 2007; 57
Avina-Zubieta ( key 20180328150036_kex286-B336) 2003; 12
Roberts ( key 20180328150036_kex286-B293) 2015; 57
Callen ( key 20180328150036_kex286-B141) 1991; 47
Kronbichler ( key 20180328150036_kex
29893921 - Rheumatology (Oxford). 2018 Aug 1;57(8):1502-1503. doi: 10.1093/rheumatology/key170.
29893930 - Rheumatology (Oxford). 2018 Aug 1;57(8):1501-1502. doi: 10.1093/rheumatology/key168.
29253280 - Rheumatology (Oxford). 2018 Jan 1;57(1):12-13. doi: 10.1093/rheumatology/kex450.
References_xml – volume: 48
  start-page: 691
  year: 2009
  ident: key 20180328150036_kex286-B268
  article-title: The BILAG-2004 index is sensitive to change for assessment of SLE disease activity
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kep064
– volume: 19
  start-page: 395
  year: 2001
  ident: key 20180328150036_kex286-B111
  article-title: Risk factors associated with mortality in systemic lupus erythematosus. A case–control study in a tertiary care center in Mexico City
  publication-title: Clin Exp Rheumatol
– volume: 9
  start-page: 566
  year: 2000
  ident: key 20180328150036_kex286-B320
  article-title: Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/096120300678828794
– volume: 12
  start-page: 1118
  year: 1985
  ident: key 20180328150036_kex286-B341
  article-title: Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives
  publication-title: J Rheumatol
– volume: 26
  start-page: 808
  year: 1999
  ident: key 20180328150036_kex286-B115
  article-title: Discontinuation of antimalarial drugs in systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 41
  start-page: 300
  year: 2014
  ident: key 20180328150036_kex286-B208
  article-title: Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.121368
– volume: 49
  start-page: 723
  year: 2010
  ident: key 20180328150036_kex286-B152
  article-title: The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kep396
– volume: 9
  start-page: 92
  year: 2000
  ident: key 20180328150036_kex286-B307
  article-title: The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients
  publication-title: Lupus
  doi: 10.1191/096120300678828082
– volume: 15
  start-page: 111
  year: 2009
  ident: key 20180328150036_kex286-B114
  article-title: Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients
  publication-title: J Clin Rheumatol
  doi: 10.1097/RHU.0b013e31819d8489
– volume: 83
  start-page: 1
  year: 2004
  ident: key 20180328150036_kex286-B27
  article-title: The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”
  publication-title: Medicine
  doi: 10.1097/01.md.0000104742.42401.e2
– volume: 139
  start-page: 41
  year: 2009
  ident: key 20180328150036_kex286-B169
  article-title: Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
  publication-title: Swiss Med Wkly
– volume: 40
  start-page: 497
  year: 2014
  ident: key 20180328150036_kex286-B303
  article-title: Systemic lupus erythematosus and malignancies: a review article
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2014.04.005
– volume: 93
  start-page: e86
  year: 2014
  ident: key 20180328150036_kex286-B227
  article-title: Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis
  publication-title: Medicine
  doi: 10.1097/MD.0000000000000086
– volume: 64
  start-page: 797
  year: 2012
  ident: key 20180328150036_kex286-B25
  article-title: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.21664
– volume: 9
  start-page: 581
  year: 1991
  ident: key 20180328150036_kex286-B131
  article-title: Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases
  publication-title: Clin Exp Rheumatol
– volume: 7
  start-page: 562
  year: 2014
  ident: key 20180328150036_kex286-B171
  article-title: Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
  publication-title: Clin Kidney J
  doi: 10.1093/ckj/sfu096
– volume: 29
  start-page: 2555
  year: 2002
  ident: key 20180328150036_kex286-B342
  article-title: Specific antibody response after influenza immunization in systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 8
  start-page: 705
  year: 1999
  ident: key 20180328150036_kex286-B219
  article-title: A study of 20 SLE patients with intravenous immunoglobulin—clinical and serologic response
  publication-title: Lupus
  doi: 10.1191/096120399678841007
– volume: 1
  start-page: e000031
  year: 2014
  ident: key 20180328150036_kex286-B360
  article-title: Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials
  publication-title: Lupus Sci Med
  doi: 10.1136/lupus-2014-000031
– volume: 72
  start-page: 1280
  year: 2013
  ident: key 20180328150036_kex286-B354
  article-title: Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202844
– volume: 52
  start-page: 3073
  year: 2005
  ident: key 20180328150036_kex286-B86
  article-title: Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21358
– volume: 12
  start-page: 944
  year: 1985
  ident: key 20180328150036_kex286-B145
  article-title: Intravenous pulse methylprednisolone followed by alternate day corticosteroid therapy in lupus erythematosus: a prospective evaluation
  publication-title: J Rheumatol
– volume: 10
  start-page: 43
  year: 2010
  ident: key 20180328150036_kex286-B243
  article-title: Systemic lupus erythematosus: clinical presentations
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2010.08.016
– volume: 62
  start-page: 393
  year: 2010
  ident: key 20180328150036_kex286-B108
  article-title: Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.20097
– volume: 44
  start-page: 2342
  year: 2001
  ident: key 20180328150036_kex286-B299
  article-title: Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8
– volume: 9
  start-page: 676
  year: 2000
  ident: key 20180328150036_kex286-B181
  article-title: Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A
  publication-title: Lupus
  doi: 10.1191/096120300676096627
– volume: 59
  start-page: 1796
  year: 2008
  ident: key 20180328150036_kex286-B124
  article-title: Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24068
– volume: 21
  start-page: 37
  year: 1978
  ident: key 20180328150036_kex286-B331
  article-title: Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780210107
– volume: 37
  start-page: 322
  year: 2010
  ident: key 20180328150036_kex286-B329
  article-title: Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.090306
– volume: 33
  start-page: 45
  year: 2006
  ident: key 20180328150036_kex286-B304
  article-title: Cancer screening in patients with systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 44
  start-page: 175
  year: 2014
  ident: key 20180328150036_kex286-B200
  article-title: Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2014.04.002
– volume: 345
  start-page: 1595
  year: 1995
  ident: key 20180328150036_kex286-B60
  article-title: Prevention of relapses in systemic lupus erythematosus
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)90114-0
– volume: 66
  start-page: 608
  year: 2014
  ident: key 20180328150036_kex286-B13
  article-title: Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22173
– volume: 36
  start-page: 1195
  year: 2009
  ident: key 20180328150036_kex286-B47
  article-title: Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.081194
– volume: 63
  start-page: 3918
  year: 2011
  ident: key 20180328150036_kex286-B204
  article-title: A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.30613
– volume: 23
  start-page: 3
  year: 2014
  ident: key 20180328150036_kex286-B260
  article-title: The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary
  publication-title: Lupus
  doi: 10.1177/0961203313512883
– volume: 50
  start-page: 1424
  year: 2011
  ident: key 20180328150036_kex286-B18
  article-title: Assessment of a lupus nephritis cohort over a 30-year period
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ker101
– volume: 156
  start-page: 320
  year: 2010
  ident: key 20180328150036_kex286-B63
  article-title: Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2010.07.009
– volume: 53
  start-page: 988
  year: 2014
  ident: key 20180328150036_kex286-B78
  article-title: Therapeutic drug monitoring in rheumatic diseases: utile or futile?
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ket355
– volume: 1069
  start-page: 477
  year: 2006
  ident: key 20180328150036_kex286-B335
  article-title: Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1351.048
– volume: 23
  start-page: 873
  year: 2005
  ident: key 20180328150036_kex286-B332
  article-title: Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine
  publication-title: Clin Exp Rheumatol
– volume: 66
  start-page: 1168
  year: 2007
  ident: key 20180328150036_kex286-B112
  article-title: Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.068676
– volume: 18
  start-page: 257
  year: 2009
  ident: key 20180328150036_kex286-B290
  article-title: European consensus statement on the terminology used in the management of lupus glomerulonephritis
  publication-title: Lupus
  doi: 10.1177/0961203308100481
– volume: 25
  start-page: 397
  year: 2011
  ident: key 20180328150036_kex286-B180
  article-title: Cyclosporine A in the long-term management of systemic lupus erythematosus
  publication-title: J Biol Regul Homeost Agents
– volume: 39
  start-page: 58
  year: 2013
  ident: key 20180328150036_kex286-B100
  article-title: Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study
  publication-title: Reprod Toxicol
  doi: 10.1016/j.reprotox.2013.04.005
– volume: 73
  start-page: 958
  year: 2014
  ident: key 20180328150036_kex286-B71
  article-title: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-205139
– volume: 17
  start-page: 191
  year: 2007
  ident: key 20180328150036_kex286-B193
  article-title: A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus
  publication-title: Mod Rheumatol
  doi: 10.3109/s10165-007-0565-z
– volume: 21
  start-page: 380
  year: 2010
  ident: key 20180328150036_kex286-B57
  article-title: Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis
  publication-title: Platelets
  doi: 10.3109/09537101003735564
– volume: 21
  start-page: 1158
  year: 2012
  ident: key 20180328150036_kex286-B79
  article-title: Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring
  publication-title: Lupus
  doi: 10.1177/0961203312447868
– volume: 15
  start-page: 3
  year: 2006
  ident: key 20180328150036_kex286-B248
  article-title: Ocular manifestations of systemic lupus erythematosus: a clinical review
  publication-title: Lupus
  doi: 10.1191/0961203306lu2250rr
– volume: 74
  start-page: 1011
  year: 2015
  ident: key 20180328150036_kex286-B253
  article-title: Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204838
– volume: 15
  start-page: 268
  year: 2006
  ident: key 20180328150036_kex286-B88
  article-title: Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients
  publication-title: Lupus
  doi: 10.1191/0961203306lu2299oa
– volume: 30
  start-page: 67
  year: 2000
  ident: key 20180328150036_kex286-B173
  article-title: Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus
  publication-title: Int J Clin Lab Res
  doi: 10.1007/s005990070017
– volume: 62
  start-page: 211
  year: 2010
  ident: key 20180328150036_kex286-B159
  article-title: Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial
  publication-title: Arthritis Rheum
  doi: 10.1002/art.25052
– volume: 28
  start-page: 192
  year: 1992
  ident: key 20180328150036_kex286-B98
  article-title: A study of 100 high risk lupus pregnancies
  publication-title: Am J Reprod Immunol
  doi: 10.1111/j.1600-0897.1992.tb00789.x
– volume: 62
  start-page: 534
  year: 2003
  ident: key 20180328150036_kex286-B164
  article-title: Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.62.6.534
– volume: 66
  start-page: 369
  year: 2014
  ident: key 20180328150036_kex286-B33
  article-title: Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38238
– volume: 61
  start-page: 1152
  year: 2009
  ident: key 20180328150036_kex286-B48
  article-title: Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24741
– volume: 17
  start-page: 539
  year: 2015
  ident: key 20180328150036_kex286-B356
  article-title: B cell therapies, approved and emerging: a review of infectious risk and prevention during use
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-015-0539-7
– volume: 42
  start-page: 130
  year: 2013
  ident: key 20180328150036_kex286-B302
  article-title: Cancer risk in systemic lupus: an updated international multi-centre cohort study
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2012.12.009
– volume: 74
  start-page: 319
  year: 1990
  ident: key 20180328150036_kex286-B26
  article-title: SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up
  publication-title: Q J Med
– ident: key 20180328150036_kex286-B363
– volume: 127
  start-page: 515
  year: 1991
  ident: key 20180328150036_kex286-B158
  article-title: Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1991.04510010083008
– volume: 2
  start-page: e000066
  year: 2015
  ident: key 20180328150036_kex286-B306
  article-title: Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort
  publication-title: Lupus Sci Med
  doi: 10.1136/lupus-2014-000066
– volume: 19
  start-page: 741
  year: 2005
  ident: key 20180328150036_kex286-B42
  article-title: Investigations and management of gastrointestinal and hepatic manifestations of systemic lupus erythematosus
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2005.04.002
– volume: 24
  start-page: 648
  year: 1981
  ident: key 20180328150036_kex286-B346
  article-title: Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780240503
– volume: 288
  start-page: 122
  year: 1973
  ident: key 20180328150036_kex286-B150
  article-title: Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197301182880303
– volume: 32
  start-page: 370
  year: 2003
  ident: key 20180328150036_kex286-B325
  article-title: Intravenous pulses of methylprednisolone for systemic lupus erythematosus
  publication-title: Semin Arthritis Rheum
  doi: 10.1053/sarh.2002.50003
– volume: 57
  start-page: 972
  year: 2007
  ident: key 20180328150036_kex286-B277
  article-title: Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22881
– volume: 46
  start-page: 1757
  year: 2007
  ident: key 20180328150036_kex286-B249
  article-title: Ocular manifestations of systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kem173
– volume: 126
  start-page: 76
  year: 2012
  ident: key 20180328150036_kex286-B312
  article-title: Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody associated cardiac manifestations of neonatal lupus
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.089268
– volume: 68
  start-page: 238
  year: 2009
  ident: key 20180328150036_kex286-B101
  article-title: Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.093013
– volume: 118
  start-page: 4714
  year: 2011
  ident: key 20180328150036_kex286-B254
  article-title: Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
  publication-title: Blood
  doi: 10.1182/blood-2011-03-340232
– volume: 48–49
  start-page: 10
  year: 2014
  ident: key 20180328150036_kex286-B259
  article-title: Diagnostic criteria for systemic lupus erythematosus: a critical review
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2014.01.004
– volume: 67
  start-page: 74
  year: 2008
  ident: key 20180328150036_kex286-B301
  article-title: The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.069039
– volume: 54
  start-page: 2550
  year: 2006
  ident: key 20180328150036_kex286-B9
  article-title: Mortality in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21955
– volume: 62
  start-page: 863
  year: 2010
  ident: key 20180328150036_kex286-B102
  article-title: The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27289
– volume: 40
  start-page: 27
  year: 1997
  ident: key 20180328150036_kex286-B175
  article-title: Long-term treatment of systemic lupus erythematosus with cyclosporin A
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400106
– volume: 64
  start-page: 1215
  year: 2012
  ident: key 20180328150036_kex286-B352
  article-title: Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34359
– volume: 382
  start-page: 809
  year: 2013
  ident: key 20180328150036_kex286-B20
  article-title: Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)60889-2
– volume: 54
  start-page: 3623
  year: 2006
  ident: key 20180328150036_kex286-B46
  article-title: The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22198
– volume: 50
  start-page: 2580
  year: 2004
  ident: key 20180328150036_kex286-B192
  article-title: B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20430
– volume: 74
  start-page: 1706
  year: 2015
  ident: key 20180328150036_kex286-B14
  article-title: Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-205171
– volume: 278
  start-page: 1019
  year: 1968
  ident: key 20180328150036_kex286-B153
  article-title: Controlled study of azathioprine in lupus
  publication-title: N Engl J Med
  doi: 10.1056/NEJM196805022781818
– volume: 36
  start-page: 89
  year: 2009
  ident: key 20180328150036_kex286-B156
  article-title: Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.070968
– volume: 21
  start-page: 1457
  year: 1994
  ident: key 20180328150036_kex286-B82
  article-title: Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 12
  start-page: 3
  year: 2003
  ident: key 20180328150036_kex286-B187
  article-title: Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study)
  publication-title: Lupus
  doi: 10.1191/0961203303lu251oa
– volume: 40
  start-page: 1725
  year: 1997
  ident: key 20180328150036_kex286-B256
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400928
– volume: 29
  start-page: 1198
  year: 2002
  ident: key 20180328150036_kex286-B280
  article-title: Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
  publication-title: J Rheumatol
– volume: 170
  start-page: 737
  year: 2015
  ident: key 20180328150036_kex286-B401
  article-title: A proposal: the need for thrombotic thrombocytopenic purpura Specialist Centres – providing better outcomes
  publication-title: Br J Haematol
  doi: 10.1111/bjh.13568
– volume: 29
  start-page: 2507
  year: 2002
  ident: key 20180328150036_kex286-B334
  article-title: Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine
  publication-title: J Rheumatol
– volume: 24
  start-page: 1608
  year: 1997
  ident: key 20180328150036_kex286-B276
  article-title: Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 35
  start-page: 669
  year: 1996
  ident: key 20180328150036_kex286-B174
  article-title: Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study
  publication-title: Br J Rheumatol
  doi: 10.1093/rheumatology/35.7.669
– volume: 43
  start-page: 352
  year: 2013
  ident: key 20180328150036_kex286-B12
  article-title: The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2013.05.003
– volume: 39
  start-page: 1301
  year: 2000
  ident: key 20180328150036_kex286-B213
  article-title: Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/39.11.1301
– volume: 40
  start-page: 27
  year: 2011
  ident: key 20180328150036_kex286-B65
  article-title: Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-009-8190-6
– volume: 52
  start-page: 2761
  year: 2005
  ident: key 20180328150036_kex286-B376
  article-title: Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21263
– volume: 22
  start-page: 1489
  year: 2013
  ident: key 20180328150036_kex286-B201
  article-title: Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
  publication-title: Lupus
  doi: 10.1177/0961203313509295
– volume: 21
  start-page: 1674
  year: 1994
  ident: key 20180328150036_kex286-B126
  article-title: A 2 year, open ended trial of methotrexate in systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 16
  start-page: 256
  year: 2000
  ident: key 20180328150036_kex286-B137
  article-title: Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test
  publication-title: Photodermatol Photoimmunol Photomed
  doi: 10.1034/j.1600-0781.2000.160604.x
– volume: 71
  start-page: 1833
  year: 2012
  ident: key 20180328150036_kex286-B359
  article-title: Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2011-200831
– volume: 32
  start-page: 1047
  year: 2005
  ident: key 20180328150036_kex286-B163
  article-title: Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients
  publication-title: J Rheumatol
– volume: 15
  start-page: 38
  year: 2016
  ident: key 20180328150036_kex286-B238
  article-title: Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2015.08.010
– volume: 15
  start-page: 62
  year: 2012
  ident: key 20180328150036_kex286-B125
  article-title: Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus
  publication-title: Int J Rheum Dis
  doi: 10.1111/j.1756-185X.2011.01665.x
– volume: 71
  start-page: 1343
  year: 2012
  ident: key 20180328150036_kex286-B206
  article-title: Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2011-200937
– volume: 75
  start-page: 136
  year: 2016
  ident: key 20180328150036_kex286-B4
  article-title: The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2014-206334
– volume: 46
  start-page: 1471
  year: 2007
  ident: key 20180328150036_kex286-B54
  article-title: Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kem153
– volume: 23
  start-page: 516
  year: 2014
  ident: key 20180328150036_kex286-B139
  article-title: Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus
  publication-title: Exp Dermatol
  doi: 10.1111/exd.12428
– volume: 26
  start-page: 80
  year: 2016
  ident: key 20180328150036_kex286-B197
  article-title: Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
  publication-title: Mod Rheumatol
  doi: 10.3109/14397595.2015.1060665
– volume: 69
  start-page: 1269
  year: 2010
  ident: key 20180328150036_kex286-B74
  article-title: European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2009.117200
– volume: 365
  start-page: 1886
  year: 2011
  ident: key 20180328150036_kex286-B160
  article-title: Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1014460
– volume: 12
  start-page: 52
  year: 2003
  ident: key 20180328150036_kex286-B336
  article-title: Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203303lu337oa
– volume: 6
  start-page: 385
  year: 1997
  ident: key 20180328150036_kex286-B128
  article-title: Methotrexate use in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/096120339700600407
– volume: 13
  start-page: 679
  year: 2004
  ident: key 20180328150036_kex286-B273
  article-title: Evaluation of systemic lupus erythematosus activity during pregnancy
  publication-title: Lupus
  doi: 10.1191/0961203304lu1099oa
– volume: 54
  start-page: 868
  year: 2015
  ident: key 20180328150036_kex286-B105
  article-title: The clinically quiescent phase in early-diagnosed SLE patients: inception cohort study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu406
– volume: 51
  start-page: 491
  year: 2012
  ident: key 20180328150036_kex286-B11
  article-title: Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ker368
– volume: 34
  start-page: 263
  year: 2015
  ident: key 20180328150036_kex286-B199
  article-title: The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosus
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-014-2839-0
– volume: 18
  start-page: 735
  year: 2009
  ident: key 20180328150036_kex286-B308
  article-title: Treatment of lupus skin involvement with quinacrine and hydroxychloroquine
  publication-title: Lupus
  doi: 10.1177/0961203308101714
– volume: 10
  start-page: 705
  year: 2011
  ident: key 20180328150036_kex286-B99
  article-title: Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy
  publication-title: Expert Opin Drug Saf
  doi: 10.1517/14740338.2011.566555
– volume: 51
  start-page: 476
  year: 2012
  ident: key 20180328150036_kex286-B194
  article-title: Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ker337
– volume: 20
  start-page: 1219
  year: 2011
  ident: key 20180328150036_kex286-B383
  article-title: Rituximab induces a rapid and sustained remission in Colombian patients with severe and refractory systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203311409273
– volume: 55
  start-page: 1698
  year: 2016
  ident: key 20180328150036_kex286-B240
  article-title: BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kev405
– volume: 39
  start-page: 377
  year: 1980
  ident: key 20180328150036_kex286-B147
  article-title: Methylprednisolone pulse therapy for nonrenal lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.39.4.377
– volume: 62
  start-page: 1487
  year: 2010
  ident: key 20180328150036_kex286-B188
  article-title: High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27371
– volume: 41
  start-page: 643
  year: 2002
  ident: key 20180328150036_kex286-B87
  article-title: Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/41.6.643
– volume: 47
  start-page: 646
  year: 2008
  ident: key 20180328150036_kex286-B221
  article-title: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ken046
– volume: 34
  start-page: 501
  year: 2004
  ident: key 20180328150036_kex286-B36
  article-title: Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2004.07.002
– volume: 62
  start-page: 2458
  year: 2010
  ident: key 20180328150036_kex286-B387
  article-title: Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27541
– volume: 46
  start-page: 2121
  year: 2002
  ident: key 20180328150036_kex286-B368
  article-title: Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10461
– volume: 1
  start-page: 366
  year: 1997
  ident: key 20180328150036_kex286-B399
  article-title: Plasmapheresis in the treatment of rapidly progressive glomerulonephritis
  publication-title: Ther Apher
  doi: 10.1111/j.1744-9987.1997.tb00057.x
– volume: 23
  start-page: 71
  year: 1996
  ident: key 20180328150036_kex286-B218
  article-title: High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study
  publication-title: J Rheumatol
– volume: 50
  start-page: 3045
  year: 2004
  ident: key 20180328150036_kex286-B140
  article-title: Use of sunscreens to protect against ultraviolet-induced lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20426
– volume: 65
  start-page: e195
  year: 2011
  ident: key 20180328150036_kex286-B288
  article-title: Cutaneous lupus erythematosus: update of therapeutic options. Part II
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2010.06.017
– volume: 61
  start-page: 1168
  year: 2009
  ident: key 20180328150036_kex286-B205
  article-title: A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24699
– volume: 10
  start-page: 383
  year: 2011
  ident: key 20180328150036_kex286-B278
  article-title: Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2010.12.008
– volume: 65
  start-page: e179
  year: 2011
  ident: key 20180328150036_kex286-B287
  article-title: Cutaneous lupus erythematosus: update of therapeutic options. Part I
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2010.06.018
– volume: 52
  start-page: 2108
  year: 2013
  ident: key 20180328150036_kex286-B31
  article-title: Effect of gender on clinical presentation in systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ket160
– volume: 1
  start-page: 645
  year: 1972
  ident: key 20180328150036_kex286-B330
  article-title: Azathioprine in connective tissue disorders
  publication-title: Br Med J
  doi: 10.1136/bmj.1.5801.645
– volume: 55
  start-page: 252
  year: 2016
  ident: key 20180328150036_kex286-B19
  article-title: The frequency and outcome of lupus nephritis: results from an international inception cohort study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kev311
– volume: 60
  start-page: 3761
  year: 2009
  ident: key 20180328150036_kex286-B355
  article-title: Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24966
– volume: 33
  start-page: 1578
  year: 2006
  ident: key 20180328150036_kex286-B282
  article-title: Inter-hospital transfers of patients with systemic lupus erythematosus: characteristics, predictors, and outcomes
  publication-title: J Rheumatol
– volume: 10
  start-page: 480
  year: 2001
  ident: key 20180328150036_kex286-B185
  article-title: Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study
  publication-title: Lupus
  doi: 10.1191/096120301678416033
– volume: 69
  start-page: 2083
  year: 2010
  ident: key 20180328150036_kex286-B161
  article-title: Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.131995
– volume: 6 (Suppl 1)
  start-page: 39
  year: 1983
  ident: key 20180328150036_kex286-B232
  article-title: Plasma exchange in systemic lupus erythematosus
  publication-title: Int J Artif Organs
– volume: 64
  start-page: 1366
  year: 2005
  ident: key 20180328150036_kex286-B52
  article-title: Lupus thrombocytopenia: clinical implications and prognostic significance
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.033100
– volume: 115
  start-page: 59
  year: 2003
  ident: key 20180328150036_kex286-B328
  article-title: Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(03)00135-9
– ident: key 20180328150036_kex286-B324
– volume: 358
  start-page: 929
  year: 2008
  ident: key 20180328150036_kex286-B1
  article-title: Systemic lupus erythematosus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra071297
– volume: 3
  start-page: 273
  ident: key 20180328150036_kex286-B134
  article-title: Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus
  publication-title: Expert Opin Drug Saf 2004;
  doi: 10.1517/14740338.3.4.273
– volume: 72
  start-page: 634
  year: 2015
  ident: key 20180328150036_kex286-B122
  article-title: Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2014.12.025
– volume: 66
  start-page: 1627
  year: 2007
  ident: key 20180328150036_kex286-B345
  article-title: A closer look at non-Hodgkin’s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case–control study
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.067108
– volume: 32
  start-page: 41
  year: 2014
  ident: key 20180328150036_kex286-B222
  article-title: Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre
  publication-title: Clin Exp Rheumatol
– volume: 67
  start-page: 500
  year: 2008
  ident: key 20180328150036_kex286-B32
  article-title: Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.076059
– volume: 19
  start-page: 616
  year: 2009
  ident: key 20180328150036_kex286-B182
  article-title: Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study
  publication-title: Mod Rheumatol
  doi: 10.3109/s10165-009-0220-y
– volume: 48
  start-page: 166
  year: 2003
  ident: key 20180328150036_kex286-B375
  article-title: High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10752
– volume: 38
  start-page: 39
  year: 2005
  ident: key 20180328150036_kex286-B39
  article-title: Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
  publication-title: Autoimmunity
  doi: 10.1080/08916930400022616
– volume: 72
  start-page: 1308
  year: 2013
  ident: key 20180328150036_kex286-B76
  article-title: Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202106
– volume: 51
  start-page: 11
  year: 2014
  ident: key 20180328150036_kex286-B398
  article-title: Trends in the diagnosis and management of TTP: European perspective
  publication-title: Transfus Apher Sci
  doi: 10.1016/j.transci.2014.08.001
– volume: 10
  start-page: 152
  year: 2001
  ident: key 20180328150036_kex286-B333
  article-title: Azathioprine therapy for patients with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/096120301676669495
– volume: 29
  start-page: 769
  year: 1981
  ident: key 20180328150036_kex286-B231
  article-title: Plasmapheresis in the treatment of systemic lupus erythematosus
  publication-title: Arch Immunol Ther Exp
– volume: 11
  start-page: 357
  year: 2012
  ident: key 20180328150036_kex286-B396
  article-title: Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2011.10.009
– volume: 50
  start-page: 1640
  year: 2011
  ident: key 20180328150036_kex286-B389
  article-title: Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus—a prospective pilot study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ker176
– volume: 18
  start-page: 67
  year: 2009
  ident: key 20180328150036_kex286-B395
  article-title: Effects of rituximab on resistant SLE disease including lung involvement
  publication-title: Lupus
  doi: 10.1177/0961203308094653
– volume: 15
  start-page: 521
  year: 2006
  ident: key 20180328150036_kex286-B119
  article-title: The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters
  publication-title: Lupus
  doi: 10.1191/0961203306lu2345oa
– volume: 350
  start-page: 971
  year: 2004
  ident: key 20180328150036_kex286-B370
  article-title: Sequential therapies for proliferative lupus nephritis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa031855
– volume: 64
  start-page: 132
  year: 2012
  ident: key 20180328150036_kex286-B34
  article-title: Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.20648
– volume: 19
  start-page: 213
  year: 2010
  ident: key 20180328150036_kex286-B388
  article-title: Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients
  publication-title: Lupus
  doi: 10.1177/0961203309351541
– volume: 15
  start-page: 700
  year: 2006
  ident: key 20180328150036_kex286-B117
  article-title: Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL)
  publication-title: Lupus
  doi: 10.1177/0961203306072426
– volume: 62
  start-page: 1138
  year: 2010
  ident: key 20180328150036_kex286-B211
  article-title: Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27308
– volume: 149
  start-page: 131
  year: 2003
  ident: key 20180328150036_kex286-B323
  article-title: Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol
  publication-title: Br J Dermatol
  doi: 10.1046/j.1365-2133.2003.05379.x
– volume: 17
  start-page: 494
  year: 2014
  ident: key 20180328150036_kex286-B374
  article-title: Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.12337
– volume: 61
  start-page: 70
  year: 2002
  ident: key 20180328150036_kex286-B296
  article-title: Autoimmune thyroid disease in systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.61.1.70
– volume: 53
  start-page: 1130
  year: 2014
  ident: key 20180328150036_kex286-B30
  article-title: A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ket488
– volume: 47
  start-page: 496
  year: 1988
  ident: key 20180328150036_kex286-B144
  article-title: A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.47.6.496
– volume: 10
  start-page: 401
  year: 2001
  ident: key 20180328150036_kex286-B84
  article-title: Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
  publication-title: Lupus
  doi: 10.1191/096120301678646137
– volume: 61
  start-page: 65
  year: 2016
  ident: key 20180328150036_kex286-B250
  article-title: Systemic lupus erythematosus: an update for ophthalmologists
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2015.06.003
– volume: 38
  start-page: 917
  year: 1999
  ident: key 20180328150036_kex286-B247
  article-title: A review of gastrointestinal manifestations of systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/38.10.917
– volume: 18
  start-page: 394
  year: 2009
  ident: key 20180328150036_kex286-B165
  article-title: Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study
  publication-title: Lupus
  doi: 10.1177/0961203308099242
– volume: 66
  start-page: 1173
  year: 2007
  ident: key 20180328150036_kex286-B297
  article-title: Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.062984
– volume: 19
  start-page: 949
  year: 2010
  ident: key 20180328150036_kex286-B72
  article-title: Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203310366572
– volume: 23
  start-page: 549
  year: 2009
  ident: key 20180328150036_kex286-B244
  article-title: Challenges of ethnicity in SLE
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2009.04.005
– volume: 18
  start-page: 89
  year: 1999
  ident: key 20180328150036_kex286-B136
  article-title: Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus
  publication-title: P R Health Sci J
– volume: 5
  start-page: 237
  year: 1996
  ident: key 20180328150036_kex286-B83
  article-title: Controlled trial with chloroquine diphosphate in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/096120339600500313
– volume: 11
  start-page: 340
  year: 2002
  ident: key 20180328150036_kex286-B321
  article-title: Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE
  publication-title: Lupus
  doi: 10.1191/0961203302lu204oa
– volume: 25
  start-page: 67
  year: 2016
  ident: key 20180328150036_kex286-B298
  article-title: Autoimmune thyroid disease in a cohort of Malaysian SLE patients: frequency, clinical and immunological associations
  publication-title: Lupus
  doi: 10.1177/0961203315593164
– volume: 29
  start-page: 219
  year: 2005
  ident: key 20180328150036_kex286-B226
  article-title: Intravenous immunoglobulin therapy and systemic lupus erythematosus
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1385/CRIAI:29:3:219
– volume: 20
  start-page: 182
  year: 2011
  ident: key 20180328150036_kex286-B252
  article-title: ‘Criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010
  publication-title: Lupus
  doi: 10.1177/0961203310395055
– volume: 66
  start-page: 470
  year: 2007
  ident: key 20180328150036_kex286-B381
  article-title: Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.057885
– volume: 22
  start-page: 1142
  year: 2013
  ident: key 20180328150036_kex286-B195
  article-title: Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
  publication-title: Lupus
  doi: 10.1177/0961203313503912
– volume: 54
  start-page: 2970
  year: 2006
  ident: key 20180328150036_kex286-B391
  article-title: Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22046
– volume: 41
  start-page: 347
  year: 1982
  ident: key 20180328150036_kex286-B146
  article-title: Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.41.4.347
– volume: 27
  start-page: 2146
  year: 2000
  ident: key 20180328150036_kex286-B279
  article-title: Hospital experience and expected mortality in patients with systemic lupus erythematosus: a hospital level analysis
  publication-title: J Rheumatol
– volume: 64
  start-page: 2677
  year: 2012
  ident: key 20180328150036_kex286-B258
  article-title: Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34473
– volume: 23
  start-page: 1005
  year: 1996
  ident: key 20180328150036_kex286-B132
  article-title: Methotrexate in nonrenal lupus and undifferentiated connective tissue disease—a review of 36 patients
  publication-title: J Rheumatol
– volume: 37
  start-page: 1822
  year: 2010
  ident: key 20180328150036_kex286-B62
  article-title: Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.100007
– volume: 38
  start-page: 60
  year: 2011
  ident: key 20180328150036_kex286-B77
  article-title: Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.100575
– volume: 69
  start-page: 20
  year: 2010
  ident: key 20180328150036_kex286-B121
  article-title: Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.101766
– volume: 15
  start-page: 76
  year: 2006
  ident: key 20180328150036_kex286-B179
  article-title: Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203306lu2266oa
– volume: 20
  start-page: 206
  year: 2011
  ident: key 20180328150036_kex286-B241
  article-title: Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
  publication-title: Lupus
  doi: 10.1177/0961203310395803
– volume: 24
  start-page: 1827
  year: 2013
  ident: key 20180328150036_kex286-B295
  article-title: Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-012-2157-9
– volume: 52
  start-page: 242
  year: 1973
  ident: key 20180328150036_kex286-B364
  article-title: An approach to the use of immunosuppressive drugs in nonmalignant diseases
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(73)90062-6
– volume: 25
  start-page: 3586
  year: 2010
  ident: key 20180328150036_kex286-B392
  article-title: Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfq256
– volume: 10
  start-page: 55
  year: 2008
  ident: key 20180328150036_kex286-B215
  article-title: Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases
  publication-title: Isr Med Assoc J
– volume: 54
  start-page: 405
  year: 2015
  ident: key 20180328150036_kex286-B300
  article-title: Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu343
– volume: 16
  start-page: 154
  year: 1973
  ident: key 20180328150036_kex286-B365
  article-title: Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780160204
– volume: 64
  start-page: 913
  year: 2005
  ident: key 20180328150036_kex286-B390
  article-title: Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.029694
– volume: 23
  start-page: 393
  year: 2005
  ident: key 20180328150036_kex286-B347
  article-title: Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil
  publication-title: Clin Exp Rheumatol
– volume: 70
  start-page: 54
  year: 2011
  ident: key 20180328150036_kex286-B284
  article-title: An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.132068
– volume: 54
  start-page: 2963
  year: 2006
  ident: key 20180328150036_kex286-B17
  article-title: The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22079
– volume: 33
  start-page: 217
  year: 2004
  ident: key 20180328150036_kex286-B28
  article-title: Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center
  publication-title: Semin Arthritis Rheum
  doi: 10.1053/S0049-0172(03)00133-1
– volume: 15
  start-page: 94
  year: 2006
  ident: key 20180328150036_kex286-B92
  article-title: Sustained remission of lupus nephritis
  publication-title: Lupus
  doi: 10.1191/0961203306lu2271oa
– volume: 52
  start-page: 1646
  year: 2005
  ident: key 20180328150036_kex286-B281
  article-title: Association between physician volume and in-hospital mortality in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21053
– volume: 29
  start-page: 75
  year: 2002
  ident: key 20180328150036_kex286-B216
  article-title: Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases
  publication-title: J Rheumatol
– volume: 39
  start-page: 257
  year: 2010
  ident: key 20180328150036_kex286-B2
  article-title: Understanding the epidemiology and progression of systemic lupus erythematosus
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2008.10.007
– volume: 16
  start-page: 387
  year: 2007
  ident: key 20180328150036_kex286-B326
  article-title: High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203307079502
– volume: 377
  start-page: 721
  year: 2011
  ident: key 20180328150036_kex286-B203
  article-title: Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61354-2
– volume: 19
  start-page: 162
  year: 2010
  ident: key 20180328150036_kex286-B178
  article-title: Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice
  publication-title: Lupus
  doi: 10.1177/0961203309350320
– volume: 64
  start-page: 620
  year: 2005
  ident: key 20180328150036_kex286-B186
  article-title: Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.025528
– volume: 42
  start-page: 551
  year: 2015
  ident: key 20180328150036_kex286-B358
  article-title: Progressive multifocal leukoencephalopathy associated with belimumab in a patient with systemic lupus erythematosus
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.140577
– volume: 22
  start-page: 1286
  year: 2013
  ident: key 20180328150036_kex286-B292
  article-title: Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
  publication-title: Lupus
  doi: 10.1177/0961203313493032
– volume: 22
  start-page: 559
  year: 2013
  ident: key 20180328150036_kex286-B322
  article-title: Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.3437
– volume: 142(12 Pt 1)
  start-page: 953
  year: 2005
  ident: key 20180328150036_kex286-B271
  article-title: The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-142-12_Part_1-200506210-00004
– volume: 63
  start-page: 3038
  year: 2011
  ident: key 20180328150036_kex286-B384
  article-title: B cell biomarkers of rituximab responses in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.30466
– volume: 37
  start-page: 1784
  year: 1994
  ident: key 20180328150036_kex286-B233
  article-title: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780371212
– volume: 23
  start-page: 711
  year: 2014
  ident: key 20180328150036_kex286-B357
  article-title: A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab
  publication-title: Lupus
  doi: 10.1177/0961203314524292
– volume: 54
  start-page: 3284
  year: 2006
  ident: key 20180328150036_kex286-B89
  article-title: Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22156
– volume: 23
  start-page: 299
  year: 2014
  ident: key 20180328150036_kex286-B168
  article-title: Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center
  publication-title: Lupus
  doi: 10.1177/0961203313519158
– volume: 14
  start-page: 827
  year: 2005
  ident: key 20180328150036_kex286-B379
  article-title: Acute lupus myocarditis: clinical features and outcome of an oriental case series
  publication-title: Lupus
  doi: 10.1191/0961203305lu2228oa
– volume: 119
  start-page: 366
  year: 1993
  ident: key 20180328150036_kex286-B377
  article-title: Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-119-5-199309010-00003
– volume: 5 (Suppl 1)
  start-page: S16
  year: 1996
  ident: key 20180328150036_kex286-B113
  article-title: Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
  publication-title: Lupus
  doi: 10.1177/0961203396005001051
– volume: 127
  start-page: 513
  year: 1992
  ident: key 20180328150036_kex286-B85
  article-title: Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.1992.tb14851.x
– volume: 23
  start-page: 3514
  year: 2008
  ident: key 20180328150036_kex286-B348
  article-title: Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfn360
– volume: 54
  start-page: 1876
  year: 2015
  ident: key 20180328150036_kex286-B198
  article-title: Longer duration of B cell depletion is associated with better outcome
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kev036
– volume: 39
  start-page: 363
  year: 1996
  ident: key 20180328150036_kex286-B286
  article-title: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780390303
– volume: 10
  start-page: 162
  year: 2001
  ident: key 20180328150036_kex286-B317
  article-title: Methotrexate therapy in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/096120301666080831
– volume: 15
  start-page: 335
  year: 2006
  ident: key 20180328150036_kex286-B40
  article-title: Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis
  publication-title: Lupus
  doi: 10.1191/0961203306lu2308oa
– volume: 14 (Suppl 15)
  start-page: S85
  year: 1996
  ident: key 20180328150036_kex286-B224
  article-title: High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience
  publication-title: Clin Exp Rheumatol
– volume: 18
  start-page: 869
  year: 2009
  ident: key 20180328150036_kex286-B10
  article-title: The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe
  publication-title: Lupus
  doi: 10.1177/0961203309106831
– volume: 56
  start-page: 865
  year: 2017
  ident: key 20180328150036_kex286-B338
  article-title: BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kew479
– volume: 19
  start-page: 667
  year: 2010
  ident: key 20180328150036_kex286-B29
  article-title: Thirty years, five hundred patients: some lessons learned from running a lupus clinic
  publication-title: Lupus
  doi: 10.1177/0961203309358600
– volume: 74
  start-page: 313
  year: 1996
  ident: key 20180328150036_kex286-B378
  article-title: Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus
  publication-title: Nephron
  doi: 10.1159/000189327
– volume: 16
  start-page: 133
  year: 1996
  ident: key 20180328150036_kex286-B155
  article-title: Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone
  publication-title: Rheumatol Int
  doi: 10.1007/BF01419725
– volume: 55
  start-page: 799
  year: 2006
  ident: key 20180328150036_kex286-B53
  article-title: Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22224
– volume: 67
  start-page: 437
  year: 2015
  ident: key 20180328150036_kex286-B263
  article-title: Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22422
– volume: 18
  start-page: 822
  year: 2009
  ident: key 20180328150036_kex286-B107
  article-title: Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort
  publication-title: Lupus
  doi: 10.1177/0961203309104392
– volume: 31
  start-page: 245
  year: 2005
  ident: key 20180328150036_kex286-B257
  article-title: Review of classification criteria for systemic lupus erythematosus
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/j.rdc.2005.01.009
– volume: 62
  start-page: 775
  year: 2010
  ident: key 20180328150036_kex286-B120
  article-title: Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.20133
– volume: 26
  start-page: 1275
  year: 1999
  ident: key 20180328150036_kex286-B123
  article-title: Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 23
  start-page: 659
  year: 2013
  ident: key 20180328150036_kex286-B130
  article-title: The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus
  publication-title: Mod Rheumatol
  doi: 10.3109/s10165-012-0707-9
– volume: 19
  start-page: 685
  year: 2005
  ident: key 20180328150036_kex286-B264
  article-title: Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2005.03.010
– volume: 33
  start-page: 419
  year: 2014
  ident: key 20180328150036_kex286-B229
  article-title: Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-013-2312-5
– volume: 3
  start-page: e002852
  year: 2013
  ident: key 20180328150036_kex286-B209
  article-title: Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-002852
– volume: 51
  start-page: 1877
  year: 2012
  ident: key 20180328150036_kex286-B274
  article-title: The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kes158
– volume: 3
  start-page: 285
  year: 1984
  ident: key 20180328150036_kex286-B154
  article-title: Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study
  publication-title: Clin Rheumatol
  doi: 10.1007/BF02032333
– volume: 54
  start-page: 836
  year: 2015
  ident: key 20180328150036_kex286-B16
  article-title: Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu412
– volume: 39
  start-page: 1316
  year: 2000
  ident: key 20180328150036_kex286-B49
  article-title: Prognostic parameters for flare in systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/39.12.1316
– volume: 36
  start-page: 329
  year: 2007
  ident: key 20180328150036_kex286-B170
  article-title: Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009740701607042
– volume: 32
  start-page: 95
  year: 2014
  ident: key 20180328150036_kex286-B118
  article-title: Long-term evaluation of antimalarials in a Dutch SLE cohort: intolerance and other reasons for non-use
  publication-title: Clin Exp Rheumatol
– volume: 21
  start-page: 1063
  year: 2012
  ident: key 20180328150036_kex286-B385
  article-title: Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study
  publication-title: Lupus
  doi: 10.1177/0961203312446627
– volume: 23
  start-page: 318
  year: 2013
  ident: key 20180328150036_kex286-B91
  article-title: Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)
  publication-title: Mod Rheumatol
  doi: 10.3109/s10165-012-0656-3
– volume: 82
  start-page: 299
  year: 2003
  ident: key 20180328150036_kex286-B21
  article-title: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
  publication-title: Medicine
  doi: 10.1097/01.md.0000091181.93122.55
– volume: 54
  start-page: 3640
  year: 2006
  ident: key 20180328150036_kex286-B90
  article-title: Hydroxychloroquine in lupus pregnancy
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22159
– volume: 67
  start-page: 295
  year: 2009
  ident: key 20180328150036_kex286-B380
  article-title: Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus
  publication-title: Neth J Med
– volume: 72
  start-page: 1786
  year: 2013
  ident: key 20180328150036_kex286-B80
  article-title: Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202322
– volume: 42
  start-page: 247
  year: 2012
  ident: key 20180328150036_kex286-B220
  article-title: Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-011-8278-7
– volume: 27
  start-page: 309
  year: 2013
  ident: key 20180328150036_kex286-B265
  article-title: Assessment of disease activity, damage and quality of life in systemic lupus erythematosus: new aspects
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2013.10.003
– volume: 67
  start-page: 195
  year: 2008
  ident: key 20180328150036_kex286-B22
  article-title: EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.070367
– volume: 60
  start-page: 270
  year: 2014
  ident: key 20180328150036_kex286-B167
  article-title: Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature
  publication-title: Immunol Res
  doi: 10.1007/s12026-014-8609-x
– volume: 20
  start-page: 588
  year: 2011
  ident: key 20180328150036_kex286-B69
  article-title: High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203310393378
– volume: 39
  start-page: 370
  year: 1996
  ident: key 20180328150036_kex286-B56
  article-title: Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780390304
– volume: 76
  start-page: 432
  year: 1997
  ident: key 20180328150036_kex286-B327
  article-title: Cytotoxic therapy in systemic lupus erythematosus. Experience from a single center
  publication-title: Medicine
  doi: 10.1097/00005792-199711000-00006
– volume: 48
  start-page: 399
  year: 2009
  ident: key 20180328150036_kex286-B237
  article-title: A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/ken510
– volume: 20
  start-page: 250
  year: 2011
  ident: key 20180328150036_kex286-B37
  article-title: Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity
  publication-title: Lupus
  doi: 10.1177/0961203310385738
– volume: 67
  start-page: 1586
  year: 2015
  ident: key 20180328150036_kex286-B353
  article-title: Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39085
– volume: 14
  start-page: 576
  year: 2005
  ident: key 20180328150036_kex286-B66
  article-title: High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk
  publication-title: Lupus
  doi: 10.1191/0961203305lu2157oa
– volume: 16
  start-page: 724
  year: 2013
  ident: key 20180328150036_kex286-B172
  article-title: Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.12179
– volume: 41
  start-page: 876
  year: 2002
  ident: key 20180328150036_kex286-B162
  article-title: Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/41.8.876
– volume: 13
  start-page: R117
  year: 2011
  ident: key 20180328150036_kex286-B75
  article-title: Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3402
– volume: 41
  start-page: 875
  year: 2014
  ident: key 20180328150036_kex286-B35
  article-title: American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.130704
– volume: 5
  start-page: 228
  year: 1999
  ident: key 20180328150036_kex286-B225
  article-title: Treatment of severe CNS lupus with intravenous immunoglobulin
  publication-title: J Clin Rheumatol
  doi: 10.1097/00124743-199908000-00010
– volume: 62
  start-page: 845
  year: 2010
  ident: key 20180328150036_kex286-B67
  article-title: Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27286
– volume: 18
  start-page: 767
  year: 2009
  ident: key 20180328150036_kex286-B202
  article-title: Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases
  publication-title: Lupus
  doi: 10.1177/0961203309106174
– volume: 15
  start-page: 46
  year: 2004
  ident: key 20180328150036_kex286-B214
  article-title: Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE)
  publication-title: J Dermatolog Treat
  doi: 10.1080/09546630310018789
– volume: 66
  start-page: 357
  year: 2014
  ident: key 20180328150036_kex286-B7
  article-title: The incidence and prevalence of systemic lupus erythematosus, 2002–2004: The Georgia Lupus Registry
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38239
– volume: 14
  start-page: 101
  year: 2005
  ident: key 20180328150036_kex286-B318
  article-title: Methotrexate in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203305lu2043rr
– volume: 382
  start-page: 797
  year: 2013
  ident: key 20180328150036_kex286-B41
  article-title: Clinical aspects of autoimmune rheumatic diseases
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61499-3
– volume: 18
  start-page: 129
  year: 2015
  ident: key 20180328150036_kex286-B305
  article-title: Optimizing the use of existing therapies in lupus
  publication-title: Int J Rheum Dis
  doi: 10.1111/1756-185X.12551
– volume: 12
  start-page: 1039
  year: 2013
  ident: key 20180328150036_kex286-B313
  article-title: Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2013.04.006
– volume: 57
  start-page: 24
  year: 2015
  ident: key 20180328150036_kex286-B293
  article-title: Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2014.11.004
– volume: 15
  start-page: 366
  year: 2006
  ident: key 20180328150036_kex286-B93
  article-title: Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis
  publication-title: Lupus
  doi: 10.1191/0961203306lu2313oa
– volume: 24
  start-page: 1113
  year: 1981
  ident: key 20180328150036_kex286-B230
  article-title: Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780240901
– volume: 60
  start-page: 2438
  year: 2009
  ident: key 20180328150036_kex286-B343
  article-title: Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24679
– volume: 52
  start-page: 1473
  year: 2005
  ident: key 20180328150036_kex286-B110
  article-title: Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21039
– volume: 62
  start-page: 222
  year: 2010
  ident: key 20180328150036_kex286-B190
  article-title: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27233
– volume: 10
  start-page: 364
  year: 2001
  ident: key 20180328150036_kex286-B50
  article-title: Skin lesions—an indicator of disease activity in systemic lupus erythematosus?
  publication-title: Lupus
  doi: 10.1191/096120301675962535
– volume: 64
  start-page: 2328
  year: 2012
  ident: key 20180328150036_kex286-B361
  article-title: Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34400
– volume: 131
  start-page: 1981
  year: 2011
  ident: key 20180328150036_kex286-B94
  article-title: Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2011.167
– volume: 118
  start-page: 415
  year: 2011
  ident: key 20180328150036_kex286-B315
  article-title: Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2010.11.017
– volume: 56
  start-page: 382
  year: 1997
  ident: key 20180328150036_kex286-B127
  article-title: Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease)
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.56.6.382
– volume: 32
  start-page: 2150
  year: 2005
  ident: key 20180328150036_kex286-B70
  article-title: Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual
  publication-title: J Rheumatol
– volume: 59
  start-page: 487
  year: 2000
  ident: key 20180328150036_kex286-B177
  article-title: An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.59.6.487
– volume: 147
  start-page: 1261
  year: 2011
  ident: key 20180328150036_kex286-B309
  article-title: Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis
  publication-title: Arch Dermatol
  doi: 10.1001/archdermatol.2011.191
– volume: 125
  start-page: 549
  year: 1996
  ident: key 20180328150036_kex286-B367
  article-title: Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-125-7-199610010-00003
– volume: 33
  start-page: 634
  year: 1990
  ident: key 20180328150036_kex286-B59
  article-title: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780330505
– volume: 324
  start-page: 150
  year: 1991
  ident: key 20180328150036_kex286-B81
  article-title: A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199101173240303
– volume: 49
  start-page: 317
  year: 2015
  ident: key 20180328150036_kex286-B314
  article-title: A critical review of the effects of hydroxychloroquine and chloroquine on the eye
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-015-8469-8
– volume: 46
  start-page: 773
  year: 1987
  ident: key 20180328150036_kex286-B143
  article-title: A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.46.10.773
– volume: 9
  start-page: 64
  year: 2005
  ident: key 20180328150036_kex286-B234
  article-title: Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1774-9987.2005.00221.x
– ident: key 20180328150036_kex286-B267
– volume: 7
  start-page: 80
  year: 1998
  ident: key 20180328150036_kex286-B95
  article-title: A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group
  publication-title: Lupus
  doi: 10.1191/096120398678919778
– volume: 71
  start-page: 1771
  year: 2012
  ident: key 20180328150036_kex286-B24
  article-title: Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-201940
– volume: 65
  start-page: 1775
  year: 2013
  ident: key 20180328150036_kex286-B133
  article-title: Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22035
– start-page: 525
  volume-title: Systemic lupus erythematosus: a companion to rheumatology
  year: 2007
  ident: key 20180328150036_kex286-B272
– volume: 20
  start-page: 709
  year: 2011
  ident: key 20180328150036_kex286-B191
  article-title: Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)
  publication-title: Lupus
  doi: 10.1177/0961203310395802
– volume: 2
  start-page: CD002265
  year: 2013
  ident: key 20180328150036_kex286-B372
  article-title: Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
  publication-title: Cochrane Database Syst Rev
– volume: 384
  start-page: 1878
  year: 2014
  ident: key 20180328150036_kex286-B8
  article-title: Systemic lupus erythematosus
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60128-8
– start-page: 121
  year: 2002
  ident: key 20180328150036_kex286-B339
  article-title: Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation
  publication-title: Clin Transpl
– volume: 44
  start-page: 1542
  year: 2005
  ident: key 20180328150036_kex286-B394
  article-title: B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kei080
– volume: 142
  start-page: 678
  year: 2003
  ident: key 20180328150036_kex286-B64
  article-title: Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies
  publication-title: J Pediatr
  doi: 10.1067/mpd.2003.233
– volume: 19
  start-page: 239
  year: 2010
  ident: key 20180328150036_kex286-B55
  article-title: SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study
  publication-title: Lupus
  doi: 10.1177/0961203309351033
– volume: 98
  start-page: 32
  year: 1995
  ident: key 20180328150036_kex286-B371
  article-title: Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(99)80078-3
– ident: key 20180328150036_kex286-B362
– volume: 54
  start-page: 383
  year: 2015
  ident: key 20180328150036_kex286-B228
  article-title: Indications for IVIG in rheumatic diseases
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu429
– volume: 47
  start-page: 130
  year: 1991
  ident: key 20180328150036_kex286-B141
  article-title: Safety and efficacy of a broad-spectrum sunscreen in patients with discoid or subacute cutaneous lupus erythematosus
  publication-title: Cutis
– volume: 67
  start-page: 829
  year: 2008
  ident: key 20180328150036_kex286-B106
  article-title: Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.077594
– volume: 64
  start-page: 3364
  year: 2012
  ident: key 20180328150036_kex286-B207
  article-title: Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34564
– volume: 6
  start-page: 305
  year: 1994
  ident: key 20180328150036_kex286-B223
  article-title: Intravenous immunoglobulin therapy for rheumatic diseases
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/00002281-199405000-00011
– volume: 13
  start-page: 105
  year: 2004
  ident: key 20180328150036_kex286-B189
  article-title: Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203304lu509oa
– volume: 46
  start-page: 995
  year: 2002
  ident: key 20180328150036_kex286-B45
  article-title: Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10142
– volume: 23
  start-page: 225
  year: 2014
  ident: key 20180328150036_kex286-B319
  article-title: Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy
  publication-title: Lupus
  doi: 10.1177/0961203313519159
– volume: 18
  start-page: 516
  year: 2009
  ident: key 20180328150036_kex286-B166
  article-title: Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years
  publication-title: Lupus
  doi: 10.1177/0961203308099471
– volume: 43
  start-page: 1039
  year: 2004
  ident: key 20180328150036_kex286-B73
  article-title: Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus—a 5-yr prospective study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keh238
– volume: 29
  start-page: 288
  year: 2002
  ident: key 20180328150036_kex286-B270
  article-title: Systemic lupus erythematosus disease activity index 2000
  publication-title: J Rheumatol
– volume: 14
  start-page: 295
  year: 1996
  ident: key 20180328150036_kex286-B373
  article-title: Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus
  publication-title: Clin Exp Rheumatol
– volume: 14
  start-page: 639
  year: 1971
  ident: key 20180328150036_kex286-B149
  article-title: Azathioprine in the treatment of systemic lupus erythematosus. A controlled study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780140511
– volume: 28
  start-page: 468
  year: 2010
  ident: key 20180328150036_kex286-B382
  article-title: Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
  publication-title: Clin Exp Rheumatol
– volume: 20
  start-page: 1494
  year: 2011
  ident: key 20180328150036_kex286-B68
  article-title: Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?
  publication-title: Lupus
  doi: 10.1177/0961203311418706
– volume: 30
  start-page: 1508
  year: 2003
  ident: key 20180328150036_kex286-B351
  article-title: Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 55
  start-page: 957
  year: 2015
  ident: key 20180328150036_kex286-B316
  article-title: Hydroxychloroquine-related retinal toxicity
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kev357
– volume: 83
  start-page: 597
  year: 1975
  ident: key 20180328150036_kex286-B151
  article-title: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-83-5-597
– volume: 15
  start-page: 223
  year: 2006
  ident: key 20180328150036_kex286-B217
  article-title: Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases
  publication-title: Lupus
  doi: 10.1191/0961203306lu2292oa
– volume: 34
  start-page: 1217
  year: 2015
  ident: key 20180328150036_kex286-B251
  article-title: Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-015-2941-y
– volume: 20
  start-page: 265
  year: 1994
  ident: key 20180328150036_kex286-B157
  article-title: Immunosuppressive drug therapy of systemic lupus erythematosus
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/S0889-857X(21)00234-9
– volume: 21
  start-page: 958
  year: 2012
  ident: key 20180328150036_kex286-B138
  article-title: Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls
  publication-title: Exp Dermatol
  doi: 10.1111/exd.12035
– volume: 148
  start-page: 479
  year: 2012
  ident: key 20180328150036_kex286-B311
  article-title: Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study
  publication-title: Arch Dermatol
  doi: 10.1001/archdermatol.2011.2558
– volume: 38
  start-page: 551
  year: 1995
  ident: key 20180328150036_kex286-B5
  article-title: The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780380415
– volume: 55
  start-page: 1693
  year: 2016
  ident: key 20180328150036_kex286-B239
  article-title: BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kev404
– volume: 34
  start-page: 1211
  year: 2015
  ident: key 20180328150036_kex286-B340
  article-title: Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-015-2987-x
– volume: 34
  start-page: 593
  year: 2004
  ident: key 20180328150036_kex286-B397
  article-title: Intravenous immunoglobulin and the kidney—a two-edged sword
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2004.06.003
– volume: 34
  start-page: 498
  year: 2009
  ident: key 20180328150036_kex286-B344
  article-title: Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients
  publication-title: Acta Reumatol Port
– volume: 61
  start-page: 830
  year: 2009
  ident: key 20180328150036_kex286-B104
  article-title: Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24538
– volume: 48
  start-page: 673
  year: 2009
  ident: key 20180328150036_kex286-B15
  article-title: Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kep062
– volume: 48
  start-page: 3207
  year: 2003
  ident: key 20180328150036_kex286-B97
  article-title: Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11304
– volume: 49
  start-page: 128
  year: 2010
  ident: key 20180328150036_kex286-B350
  article-title: Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kep346
– volume: 35
  start-page: 1118
  year: 1982
  ident: key 20180328150036_kex286-B38
  article-title: Antinuclear antibody-negative systemic lupus erythematosus-how common?
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.35.10.1118
– volume: 20
  start-page: 1103
  year: 2009
  ident: key 20180328150036_kex286-B349
  article-title: Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2008101028
– volume: 326
  start-page: 1373
  year: 1992
  ident: key 20180328150036_kex286-B400
  article-title: A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199205213262101
– volume: 40
  start-page: 809
  year: 1997
  ident: key 20180328150036_kex286-B275
  article-title: The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400506
– volume: 34
  start-page: 124
  year: 2008
  ident: key 20180328150036_kex286-B393
  article-title: Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-007-8028-z
– volume: 60
  start-page: 3378
  year: 2009
  ident: key 20180328150036_kex286-B51
  article-title: Distinct subtypes of myelitis in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24937
– volume: 25
  start-page: 243
  year: 1998
  ident: key 20180328150036_kex286-B129
  article-title: Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis
  publication-title: J Rheumatol
– volume: 169
  start-page: 653
  year: 2013
  ident: key 20180328150036_kex286-B310
  article-title: Long-term response to hydroxychloroquine in patients with discoid lupus erythematosus
  publication-title: Br J Dermatol
  doi: 10.1111/bjd.12378
– volume: 24
  start-page: 260
  year: 2008
  ident: key 20180328150036_kex286-B294
  article-title: Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus
  publication-title: Photodermatol Photoimmunol Photomed
  doi: 10.1111/j.1600-0781.2008.00373.x
– volume: 47
  start-page: 924
  year: 2008
  ident: key 20180328150036_kex286-B337
  article-title: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kel216a
– volume: 37
  start-page: 551
  year: 1994
  ident: key 20180328150036_kex286-B176
  article-title: Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780370416
– volume: 69
  start-page: 1827
  year: 2010
  ident: key 20180328150036_kex286-B103
  article-title: Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2009.119263
– volume: 11
  start-page: 356
  year: 2002
  ident: key 20180328150036_kex286-B109
  article-title: Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort
  publication-title: Lupus
  doi: 10.1191/0961203302lu203ra
– volume: 36
  start-page: 2476
  year: 2009
  ident: key 20180328150036_kex286-B58
  article-title: Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.090019
– volume: 6
  start-page: 358
  year: 2010
  ident: key 20180328150036_kex286-B246
  article-title: Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2010.62
– volume: 69
  start-page: 2074
  year: 2010
  ident: key 20180328150036_kex286-B23
  article-title: EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.130476
– volume: 14
  start-page: 871
  year: 2005
  ident: key 20180328150036_kex286-B236
  article-title: Indications for plasma exchange in systemic lupus erythematosus in 2005
  publication-title: Lupus
  doi: 10.1191/0961203305lu2174rr
– volume: 44
  start-page: 2350
  year: 2001
  ident: key 20180328150036_kex286-B44
  article-title: A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A
– volume: 35
  start-page: 826
  year: 2008
  ident: key 20180328150036_kex286-B386
  article-title: Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus
  publication-title: J Rheumatol
– volume: 33
  start-page: 449
  year: 2015
  ident: key 20180328150036_kex286-B196
  article-title: Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry
  publication-title: Clin Exp Rheumatol
– volume: 42
  start-page: 599608
  year: 1999
  ident: key 20180328150036_kex286-B245
  article-title: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
  publication-title: Arthritis Rheum
– volume: 62
  start-page: 1147
  year: 2010
  ident: key 20180328150036_kex286-B212
  article-title: Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27350
– volume: 64
  start-page: 37
  year: 2011
  ident: key 20180328150036_kex286-B135
  article-title: Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2009.12.053
– volume: 17
  start-page: 3
  year: 2015
  ident: key 20180328150036_kex286-B261
  article-title: Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0521-9
– volume: 16
  start-page: 817
  year: 2007
  ident: key 20180328150036_kex286-B235
  article-title: Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients
  publication-title: Lupus
  doi: 10.1177/0961203307081840
– volume: 26
  start-page: 510
  year: 2014
  ident: key 20180328150036_kex286-B266
  article-title: Advances in the assessment of lupus disease activity and damage
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000085
– volume: 25
  start-page: 417
  year: 2011
  ident: key 20180328150036_kex286-B291
  article-title: Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?
  publication-title: Clin Transplant
  doi: 10.1111/j.1399-0012.2010.01255.x
– volume: 57
  start-page: 612
  year: 2007
  ident: key 20180328150036_kex286-B6
  article-title: Incidence of systemic lupus erythematosus in the United Kingdom, 1990–1999
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22683
– volume: 13
  start-page: 601
  year: 2004
  ident: key 20180328150036_kex286-B184
  article-title: Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1191/0961203304lu1067sr
– volume: 49
  start-page: 1665
  year: 2010
  ident: key 20180328150036_kex286-B269
  article-title: Numerical scoring for the BILAG-2004 index
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keq026
– volume: 51
  start-page: 1318
  year: 1992
  ident: key 20180328150036_kex286-B116
  article-title: Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.51.12.1318
– volume: 66
  start-page: 821
  year: 2007
  ident: key 20180328150036_kex286-B96
  article-title: Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.067835
– volume: 26
  start-page: 432
  year: 1995
  ident: key 20180328150036_kex286-B289
  article-title: Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus
  publication-title: Am J Kidney Dis
  doi: 10.1016/0272-6386(95)90488-3
– volume: 4
  start-page: 154
  year: 1974
  ident: key 20180328150036_kex286-B366
  article-title: A sequential trial comparing cyclophosphamide and azathioprine as adjuncts in the treatment of systemic lupus erythematosus
  publication-title: Aust N Z J Med
  doi: 10.1111/j.1445-5994.1974.tb03165.x
– volume: 45
  start-page: 359
  year: 1986
  ident: key 20180328150036_kex286-B43
  article-title: Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.45.5.359
– volume: 382
  start-page: 819
  year: 2013
  ident: key 20180328150036_kex286-B3
  article-title: Immunopathogenic mechanisms of systemic autoimmune disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)60954-X
– volume: 12
  start-page: 163
  year: 1994
  ident: key 20180328150036_kex286-B210
  article-title: Long-term i.v. Ig treatment in systemic lupus erythematosus
  publication-title: Clin Exp Rheumatol
– volume: 69
  start-page: 61
  year: 2010
  ident: key 20180328150036_kex286-B369
  article-title: The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.102533
– volume: 67
  start-page: 1180
  year: 2015
  ident: key 20180328150036_kex286-B262
  article-title: Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.22539
– volume: 68
  start-page: 234
  year: 2009
  ident: key 20180328150036_kex286-B285
  article-title: Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.094508
– volume: 31
  start-page: 757
  year: 2011
  ident: key 20180328150036_kex286-B183
  article-title: Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-010-1366-9
– volume: 21
  start-page: 2239
  year: 1994
  ident: key 20180328150036_kex286-B61
  article-title: Serologically active clinically quiescent systemic lupus erythematosus—predictors of clinical flares
  publication-title: J Rheumatol
– volume: 33
  start-page: 57
  year: 2006
  ident: key 20180328150036_kex286-B142
  article-title: Flares in lupus: Outcome Assessment Trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinolone
  publication-title: J Rheumatol
– volume: 25
  start-page: 1271
  year: 1982
  ident: key 20180328150036_kex286-B255
  article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780251101
– volume: 11
  start-page: 508
  year: 2002
  ident: key 20180328150036_kex286-B148
  article-title: Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications
  publication-title: Lupus
  doi: 10.1191/0961203302lu243oa
– volume: 20
  start-page: 453
  year: 2011
  ident: key 20180328150036_kex286-B283
  article-title: International consensus for a definition of disease flare in lupus
  publication-title: Lupus
  doi: 10.1177/0961203310388445
– volume: 14
  start-page: S4
  year: 2012
  ident: key 20180328150036_kex286-B242
  article-title: Unmet medical needs in systemic lupus erythematosus
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3919
– reference: 29893930 - Rheumatology (Oxford). 2018 Aug 1;57(8):1501-1502. doi: 10.1093/rheumatology/key168.
– reference: 29893921 - Rheumatology (Oxford). 2018 Aug 1;57(8):1502-1503. doi: 10.1093/rheumatology/key170.
– reference: 29253280 - Rheumatology (Oxford). 2018 Jan 1;57(1):12-13. doi: 10.1093/rheumatology/kex450.
SSID ssj0005138
Score 2.631154
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e1
SubjectTerms Adult
Disease Management
Female
Humans
Immunosuppressive agents
Lupus
Lupus Erythematosus, Systemic - diagnosis
Lupus Erythematosus, Systemic - therapy
Male
Medical diagnosis
Middle Aged
Rheumatology - standards
Symptom Assessment - standards
Systemic lupus erythematosus
United Kingdom
Title The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
URI https://www.ncbi.nlm.nih.gov/pubmed/29029350
https://www.proquest.com/docview/2306548831
https://www.proquest.com/docview/1951417489
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuiDcLBRkJiUNJa8eJEx_LqwW0HKCVeotix2GrtpsqD6nlp_HrGMd5OLSqWi7Rrp2d3c18sb9xZj4j9AYwI1me-Z6fceIFLJAe0AgBUYoiecy5zIQpFF5857v7wdeD8GA2--NkLTW13FS_L60r-R-vQhv41VTJ3sCzg1FogNfgXziCh-F4bR_3qkRu-uWPpW6AiVp5pV-NUbIyZLLPKDwZUl4MVbRazodq47g5baoNXZ5bIdeiatpc2Vaho3JJ7MS8kSs96zPkuy1BnOWFHejpHuzbDYJGiAHCqnTpbZf1silt3VB6or33RWq0pYfpYic9twuyi3RMWR5WD3422l24oLGzcGHH2oD7HmG2hHpTu21sMkBbBesJEO1oq6kzb2srS3lhSrByWaVzZeDtkT7zL5Pg_mdqHBIW7aN6lrhmEmvkFrrtQ4hids_4-OXbmF5E213Uhz_ZK14JtuUa2bJGJqxoUml5IeBpic_efXSvi1jwtoXfAzTTq4fozqLLyXiEjgCFuEMh7lCIARDYhQkeUNh2AcLwiEJc5LhHIW5RiCcoxIcrbFH4GO1__rT3YdfrtvDwVBCz2tOZHwHnzGJJZUCY4iSN8lgyrsNMxFzkiihuKL-iEMrHgkdSRBkNlNAkF0A1n6C1VbHSzxAmoQxlRBV0h0EAFoGaciW4jPKIxXk4R35_CRPV6dubbVaOkyucN0fvhg-dWnmXq09_C7653pnrvf-SbsSoEhPuhzBjMjpHr4duuNvMQ7p0pYumSiiEPAE1mlBz9NT6ffg-XxBg5yF5frNf_QLdHe-_dbRWl41-CVS6lq9azP4FD-TWEg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+British+Society+for+Rheumatology+guideline+for+the+management+of+systemic+lupus+erythematosus+in+adults&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Gordon%2C+Caroline&rft.au=Amissah-Arthur%2C+Maame-Boatemaa&rft.au=Gayed%2C+Mary&rft.au=Brown%2C+Sue&rft.date=2018-01-01&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=57&rft.issue=1&rft.spage=e1&rft.epage=e45&rft_id=info:doi/10.1093%2Frheumatology%2Fkex286&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_rheumatology_kex286
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon